JPH11316428A - Method and system for forming x-ray image - Google Patents
Method and system for forming x-ray imageInfo
- Publication number
- JPH11316428A JPH11316428A JP11020932A JP2093299A JPH11316428A JP H11316428 A JPH11316428 A JP H11316428A JP 11020932 A JP11020932 A JP 11020932A JP 2093299 A JP2093299 A JP 2093299A JP H11316428 A JPH11316428 A JP H11316428A
- Authority
- JP
- Japan
- Prior art keywords
- ray image
- silver
- photosensitive
- photothermographic material
- silver source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 60
- 229910052709 silver Inorganic materials 0.000 claims abstract description 112
- 239000004332 silver Substances 0.000 claims abstract description 112
- -1 silver halide Chemical class 0.000 claims abstract description 73
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 63
- 239000000463 material Substances 0.000 claims abstract description 53
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 27
- 230000008859 change Effects 0.000 claims abstract description 6
- 239000002245 particle Substances 0.000 claims description 21
- 238000011161 development Methods 0.000 claims description 17
- 238000010438 heat treatment Methods 0.000 claims description 17
- 230000008569 process Effects 0.000 claims description 4
- 238000009607 mammography Methods 0.000 abstract description 11
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 42
- 239000000975 dye Substances 0.000 description 25
- 150000001875 compounds Chemical class 0.000 description 22
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 22
- 239000006224 matting agent Substances 0.000 description 17
- 206010070834 Sensitisation Diseases 0.000 description 16
- 230000008313 sensitization Effects 0.000 description 16
- 239000002253 acid Substances 0.000 description 12
- 210000003557 bones of lower extremity Anatomy 0.000 description 10
- 229920000728 polyester Polymers 0.000 description 10
- 230000001235 sensitizing effect Effects 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 229910052736 halogen Inorganic materials 0.000 description 6
- 150000002367 halogens Chemical class 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 239000003446 ligand Substances 0.000 description 6
- 150000002736 metal compounds Chemical class 0.000 description 6
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 6
- 229920000139 polyethylene terephthalate Polymers 0.000 description 6
- 239000005020 polyethylene terephthalate Substances 0.000 description 6
- 239000010948 rhodium Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 239000003990 capacitor Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 150000004820 halides Chemical class 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 150000003378 silver Chemical class 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical class OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 4
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 4
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- IJAPPYDYQCXOEF-UHFFFAOYSA-N phthalazin-1(2H)-one Chemical compound C1=CC=C2C(=O)NN=CC2=C1 IJAPPYDYQCXOEF-UHFFFAOYSA-N 0.000 description 4
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 4
- 229920003207 poly(ethylene-2,6-naphthalate) Polymers 0.000 description 4
- 239000011112 polyethylene naphthalate Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 230000005070 ripening Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 229910021612 Silver iodide Inorganic materials 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 230000006911 nucleation Effects 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 229940045105 silver iodide Drugs 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- HORKYAIEVBUXGM-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoxaline Chemical class C1=CC=C2NCCNC2=C1 HORKYAIEVBUXGM-UHFFFAOYSA-N 0.000 description 2
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 2
- KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Chemical compound C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 2
- AFBBKYQYNPNMAT-UHFFFAOYSA-N 1h-1,2,4-triazol-1-ium-3-thiolate Chemical compound SC=1N=CNN=1 AFBBKYQYNPNMAT-UHFFFAOYSA-N 0.000 description 2
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical class C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 description 2
- XDECIMXTYLBMFQ-UHFFFAOYSA-N 6-chloro-2h-phthalazin-1-one Chemical compound C1=NNC(=O)C=2C1=CC(Cl)=CC=2 XDECIMXTYLBMFQ-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical group O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 108010011222 cyclo(Arg-Pro) Proteins 0.000 description 2
- 239000003989 dielectric material Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 150000002429 hydrazines Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 229940100892 mercury compound Drugs 0.000 description 2
- 150000002731 mercury compounds Chemical class 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 229910052762 osmium Inorganic materials 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004848 polyfunctional curative Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000006479 redox reaction Methods 0.000 description 2
- 229910052702 rhenium Inorganic materials 0.000 description 2
- 229910052703 rhodium Inorganic materials 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 229910052714 tellurium Inorganic materials 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical class C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PPTXVXKCQZKFBN-UHFFFAOYSA-N (S)-(-)-1,1'-Bi-2-naphthol Chemical compound C1=CC=C2C(C3=C4C=CC=CC4=CC=C3O)=C(O)C=CC2=C1 PPTXVXKCQZKFBN-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- UDATXMIGEVPXTR-UHFFFAOYSA-N 1,2,4-triazolidine-3,5-dione Chemical compound O=C1NNC(=O)N1 UDATXMIGEVPXTR-UHFFFAOYSA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- XBYRMPXUBGMOJC-UHFFFAOYSA-N 1,2-dihydropyrazol-3-one Chemical class OC=1C=CNN=1 XBYRMPXUBGMOJC-UHFFFAOYSA-N 0.000 description 1
- AIGNCQCMONAWOL-UHFFFAOYSA-N 1,3-benzoselenazole Chemical compound C1=CC=C2[se]C=NC2=C1 AIGNCQCMONAWOL-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- YHMYGUUIMTVXNW-UHFFFAOYSA-N 1,3-dihydrobenzimidazole-2-thione Chemical compound C1=CC=C2NC(S)=NC2=C1 YHMYGUUIMTVXNW-UHFFFAOYSA-N 0.000 description 1
- OXFSTTJBVAAALW-UHFFFAOYSA-N 1,3-dihydroimidazole-2-thione Chemical compound SC1=NC=CN1 OXFSTTJBVAAALW-UHFFFAOYSA-N 0.000 description 1
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 1
- ODIRBFFBCSTPTO-UHFFFAOYSA-N 1,3-selenazole Chemical class C1=C[se]C=N1 ODIRBFFBCSTPTO-UHFFFAOYSA-N 0.000 description 1
- RSINTYZGAWHRBE-UHFFFAOYSA-N 1,3-thiazole-4,5-dione Chemical class O=C1SC=NC1=O RSINTYZGAWHRBE-UHFFFAOYSA-N 0.000 description 1
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 description 1
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
- ZRHUHDUEXWHZMA-UHFFFAOYSA-N 1,4-dihydropyrazol-5-one Chemical class O=C1CC=NN1 ZRHUHDUEXWHZMA-UHFFFAOYSA-N 0.000 description 1
- LRGBKQAXMKYMHJ-UHFFFAOYSA-N 1,5-diphenyl-1,2,5,6-tetrahydro-[1,2,4]triazolo[1,2-a][1,2,4]triazole-3,7-dithione Chemical compound S=C1NC(C=2C=CC=CC=2)N(C(N2)=S)N1C2C1=CC=CC=C1 LRGBKQAXMKYMHJ-UHFFFAOYSA-N 0.000 description 1
- WFYLHMAYBQLBEM-UHFFFAOYSA-N 1-phenyl-1,2,4-triazolidine-3,5-dione Chemical compound O=C1NC(=O)NN1C1=CC=CC=C1 WFYLHMAYBQLBEM-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- USYCQABRSUEURP-UHFFFAOYSA-N 1h-benzo[f]benzimidazole Chemical compound C1=CC=C2C=C(NC=N3)C3=CC2=C1 USYCQABRSUEURP-UHFFFAOYSA-N 0.000 description 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 1
- 229940069744 2,2'-dithiobisbenzothiazole Drugs 0.000 description 1
- LVUQDNJRAHUUSB-UHFFFAOYSA-N 2,3,5,6-tetrachloro-1h-pyridine-4-thione Chemical compound SC1=C(Cl)C(Cl)=NC(Cl)=C1Cl LVUQDNJRAHUUSB-UHFFFAOYSA-N 0.000 description 1
- YTQQIHUQLOZOJI-UHFFFAOYSA-N 2,3-dihydro-1,2-thiazole Chemical compound C1NSC=C1 YTQQIHUQLOZOJI-UHFFFAOYSA-N 0.000 description 1
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 description 1
- KGLPWQKSKUVKMJ-UHFFFAOYSA-N 2,3-dihydrophthalazine-1,4-dione Chemical compound C1=CC=C2C(=O)NNC(=O)C2=C1 KGLPWQKSKUVKMJ-UHFFFAOYSA-N 0.000 description 1
- BPRYUXCVCCNUFE-UHFFFAOYSA-N 2,4,6-trimethylphenol Chemical compound CC1=CC(C)=C(O)C(C)=C1 BPRYUXCVCCNUFE-UHFFFAOYSA-N 0.000 description 1
- UDYSBOCMSIAELQ-UHFFFAOYSA-N 2-(2-hydroxypiperidin-1-yl)cyclohex-2-en-1-one Chemical compound OC1CCCCN1C1=CCCCC1=O UDYSBOCMSIAELQ-UHFFFAOYSA-N 0.000 description 1
- NREKJIIPVVKRNO-UHFFFAOYSA-N 2-(tribromomethylsulfonyl)-1,3-benzothiazole Chemical compound C1=CC=C2SC(S(=O)(=O)C(Br)(Br)Br)=NC2=C1 NREKJIIPVVKRNO-UHFFFAOYSA-N 0.000 description 1
- HIGSPBFIOSHWQG-UHFFFAOYSA-N 2-Isopropyl-1,4-benzenediol Chemical compound CC(C)C1=CC(O)=CC=C1O HIGSPBFIOSHWQG-UHFFFAOYSA-N 0.000 description 1
- RZDNXBOXSFUJAK-UHFFFAOYSA-N 2-[(dimethylamino)methyl]isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CN(C)C)C(=O)C2=C1 RZDNXBOXSFUJAK-UHFFFAOYSA-N 0.000 description 1
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 1
- DKFPBXQCCCIWLC-UHFFFAOYSA-N 2-cyano-2-phenylacetic acid Chemical class OC(=O)C(C#N)C1=CC=CC=C1 DKFPBXQCCCIWLC-UHFFFAOYSA-N 0.000 description 1
- MOXDGMSQFFMNHA-UHFFFAOYSA-N 2-hydroxybenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1O MOXDGMSQFFMNHA-UHFFFAOYSA-N 0.000 description 1
- KTWCUGUUDHJVIH-UHFFFAOYSA-N 2-hydroxybenzo[de]isoquinoline-1,3-dione Chemical compound C1=CC(C(N(O)C2=O)=O)=C3C2=CC=CC3=C1 KTWCUGUUDHJVIH-UHFFFAOYSA-N 0.000 description 1
- FLFWJIBUZQARMD-UHFFFAOYSA-N 2-mercapto-1,3-benzoxazole Chemical compound C1=CC=C2OC(S)=NC2=C1 FLFWJIBUZQARMD-UHFFFAOYSA-N 0.000 description 1
- WZXMCNSECDQCCW-UHFFFAOYSA-N 2-methyl-5-(1-phenyltetrazol-5-yl)sulfanylbenzene-1,4-diol Chemical compound C1=C(O)C(C)=CC(O)=C1SC1=NN=NN1C1=CC=CC=C1 WZXMCNSECDQCCW-UHFFFAOYSA-N 0.000 description 1
- MBRMYZHVEXFNCU-UHFFFAOYSA-N 2-methylsulfonylbenzene-1,4-diol Chemical compound CS(=O)(=O)C1=CC(O)=CC=C1O MBRMYZHVEXFNCU-UHFFFAOYSA-N 0.000 description 1
- PUPFOFVEHDNUJU-UHFFFAOYSA-N 2-sulfanylidene-1h-quinazolin-4-one Chemical compound C1=CC=C2C(=O)NC(S)=NC2=C1 PUPFOFVEHDNUJU-UHFFFAOYSA-N 0.000 description 1
- UGWULZWUXSCWPX-UHFFFAOYSA-N 2-sulfanylideneimidazolidin-4-one Chemical class O=C1CNC(=S)N1 UGWULZWUXSCWPX-UHFFFAOYSA-N 0.000 description 1
- BKZXZGWHTRCFPX-UHFFFAOYSA-N 2-tert-butyl-6-methylphenol Chemical compound CC1=CC=CC(C(C)(C)C)=C1O BKZXZGWHTRCFPX-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 description 1
- YMTYZTXUZLQUSF-UHFFFAOYSA-N 3,3'-Dimethylbisphenol A Chemical compound C1=C(O)C(C)=CC(C(C)(C)C=2C=C(C)C(O)=CC=2)=C1 YMTYZTXUZLQUSF-UHFFFAOYSA-N 0.000 description 1
- AKRDSDDYNMVKCX-UHFFFAOYSA-N 3,5-dimethylpyrazole-1-carboxamide Chemical compound CC=1C=C(C)N(C(N)=O)N=1 AKRDSDDYNMVKCX-UHFFFAOYSA-N 0.000 description 1
- NQJATJCXKYZVEL-UHFFFAOYSA-N 3-benzylsulfanyl-1h-1,2,4-triazol-5-amine Chemical compound N1C(N)=NC(SCC=2C=CC=CC=2)=N1 NQJATJCXKYZVEL-UHFFFAOYSA-N 0.000 description 1
- UERPUZBSSSAZJE-UHFFFAOYSA-N 3-chlorophthalic anhydride Chemical compound ClC1=CC=CC2=C1C(=O)OC2=O UERPUZBSSSAZJE-UHFFFAOYSA-N 0.000 description 1
- OXRSFHYBIRFJSF-UHFFFAOYSA-N 3-phenyl-1,4-dihydropyrazol-5-one Chemical compound N1C(=O)CC(C=2C=CC=CC=2)=N1 OXRSFHYBIRFJSF-UHFFFAOYSA-N 0.000 description 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical class C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 1
- RYYXDZDBXNUPOG-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical class Cl.Cl.C1C(N)CCC2=C1SC(N)=N2 RYYXDZDBXNUPOG-UHFFFAOYSA-N 0.000 description 1
- GMTAWLUJHGIUPU-UHFFFAOYSA-N 4,5-diphenyl-1,3-dihydroimidazole-2-thione Chemical compound N1C(S)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 GMTAWLUJHGIUPU-UHFFFAOYSA-N 0.000 description 1
- QCAWOHUJKPKOMD-UHFFFAOYSA-N 4,6-diamino-1h-pyrimidine-2-thione Chemical compound NC1=CC(N)=NC(S)=N1 QCAWOHUJKPKOMD-UHFFFAOYSA-N 0.000 description 1
- LWVBRIOOSVDZFO-UHFFFAOYSA-N 4-(carbamothioylamino)butanoic acid Chemical compound NC(=S)NCCCC(O)=O LWVBRIOOSVDZFO-UHFFFAOYSA-N 0.000 description 1
- CYKQJBGKWSTLHL-UHFFFAOYSA-N 4-(dimethylcarbamothioylamino)butanoic acid Chemical compound CN(C)C(=S)NCCCC(O)=O CYKQJBGKWSTLHL-UHFFFAOYSA-N 0.000 description 1
- FXAILOLNECSGMI-RUDMXATFSA-N 4-chloro-2-[(E)-hydroxyiminomethyl]phenol Chemical compound O\N=C\C1=C(O)C=CC(Cl)=C1 FXAILOLNECSGMI-RUDMXATFSA-N 0.000 description 1
- CWJJAFQCTXFSTA-UHFFFAOYSA-N 4-methylphthalic acid Chemical compound CC1=CC=C(C(O)=O)C(C(O)=O)=C1 CWJJAFQCTXFSTA-UHFFFAOYSA-N 0.000 description 1
- KXFRSVCWEHBKQT-UHFFFAOYSA-N 4-naphthalen-1-yl-2h-phthalazin-1-one Chemical compound C12=CC=CC=C2C(=O)NN=C1C1=CC=CC2=CC=CC=C12 KXFRSVCWEHBKQT-UHFFFAOYSA-N 0.000 description 1
- SLBQXWXKPNIVSQ-UHFFFAOYSA-N 4-nitrophthalic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C=C1C(O)=O SLBQXWXKPNIVSQ-UHFFFAOYSA-N 0.000 description 1
- NTFMLYSGIKHECT-UHFFFAOYSA-N 4-phenyl-1,3-oxazole Chemical compound O1C=NC(C=2C=CC=CC=2)=C1 NTFMLYSGIKHECT-UHFFFAOYSA-N 0.000 description 1
- CFIUCOKDVARZGF-UHFFFAOYSA-N 5,7-dimethoxy-2h-phthalazin-1-one Chemical compound C1=NNC(=O)C2=CC(OC)=CC(OC)=C21 CFIUCOKDVARZGF-UHFFFAOYSA-N 0.000 description 1
- WZUUZPAYWFIBDF-UHFFFAOYSA-N 5-amino-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound NC1=NNC(S)=N1 WZUUZPAYWFIBDF-UHFFFAOYSA-N 0.000 description 1
- GDGIVSREGUOIJZ-UHFFFAOYSA-N 5-amino-3h-1,3,4-thiadiazole-2-thione Chemical compound NC1=NN=C(S)S1 GDGIVSREGUOIJZ-UHFFFAOYSA-N 0.000 description 1
- CWIYBOJLSWJGKV-UHFFFAOYSA-N 5-methyl-1,3-dihydrobenzimidazole-2-thione Chemical compound CC1=CC=C2NC(S)=NC2=C1 CWIYBOJLSWJGKV-UHFFFAOYSA-N 0.000 description 1
- HOASVNMVYBSLSU-UHFFFAOYSA-N 6-ethoxy-3h-1,3-benzothiazole-2-thione Chemical compound CCOC1=CC=C2N=C(S)SC2=C1 HOASVNMVYBSLSU-UHFFFAOYSA-N 0.000 description 1
- UQJLPBLXSJWAKG-UHFFFAOYSA-N 6-methyl-1h-pyrimidin-3-ium-2-thione;chloride Chemical compound Cl.CC1=CC=NC(=S)N1 UQJLPBLXSJWAKG-UHFFFAOYSA-N 0.000 description 1
- VABISHCLVYMGAU-UHFFFAOYSA-N 7,9-dihydropurine-8-thione Chemical compound N1=CN=C2NC(S)=NC2=C1 VABISHCLVYMGAU-UHFFFAOYSA-N 0.000 description 1
- DBWDEWRMEKXOFI-UHFFFAOYSA-N 7-(trifluoromethyl)-1h-quinoline-4-thione Chemical compound SC1=CC=NC2=CC(C(F)(F)F)=CC=C21 DBWDEWRMEKXOFI-UHFFFAOYSA-N 0.000 description 1
- GNXAXTIOBXCSDE-UHFFFAOYSA-N 8-methyl-2h-phthalazin-1-one Chemical compound C1=NNC(=O)C2=C1C=CC=C2C GNXAXTIOBXCSDE-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- UIERETOOQGIECD-UHFFFAOYSA-N Angelic acid Natural products CC=C(C)C(O)=O UIERETOOQGIECD-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Chemical class 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- NVXLIZQNSVLKPO-UHFFFAOYSA-N Glucosereductone Chemical compound O=CC(O)C=O NVXLIZQNSVLKPO-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical class NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000002174 Styrene-butadiene Substances 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- 241001061127 Thione Species 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical compound [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 description 1
- XEIPQVVAVOUIOP-UHFFFAOYSA-N [Au]=S Chemical compound [Au]=S XEIPQVVAVOUIOP-UHFFFAOYSA-N 0.000 description 1
- KWEGYAQDWBZXMX-UHFFFAOYSA-N [Au]=[Se] Chemical compound [Au]=[Se] KWEGYAQDWBZXMX-UHFFFAOYSA-N 0.000 description 1
- UVJMTMRFKLJYEC-UHFFFAOYSA-N [amino(sulfanyl)methylidene]azanium;2,2,2-trifluoroacetate Chemical compound NC(S)=[NH2+].[O-]C(=O)C(F)(F)F UVJMTMRFKLJYEC-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 238000007754 air knife coating Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 150000007656 barbituric acids Chemical class 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- KXNQKOAQSGJCQU-UHFFFAOYSA-N benzo[e][1,3]benzothiazole Chemical compound C1=CC=C2C(N=CS3)=C3C=CC2=C1 KXNQKOAQSGJCQU-UHFFFAOYSA-N 0.000 description 1
- WMUIZUWOEIQJEH-UHFFFAOYSA-N benzo[e][1,3]benzoxazole Chemical compound C1=CC=C2C(N=CO3)=C3C=CC2=C1 WMUIZUWOEIQJEH-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- UORVGPXVDQYIDP-BJUDXGSMSA-N borane Chemical class [10BH3] UORVGPXVDQYIDP-BJUDXGSMSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- OAYRYNVEFFWSHK-UHFFFAOYSA-N carsalam Chemical compound C1=CC=C2OC(=O)NC(=O)C2=C1 OAYRYNVEFFWSHK-UHFFFAOYSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 150000004700 cobalt complex Chemical class 0.000 description 1
- 150000001913 cyanates Chemical class 0.000 description 1
- VEIOBOXBGYWJIT-UHFFFAOYSA-N cyclohexane;methanol Chemical compound OC.OC.C1CCCCC1 VEIOBOXBGYWJIT-UHFFFAOYSA-N 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- AUEULUAAXLGHJD-UHFFFAOYSA-N diaminophosphorylamine;phenol Chemical class NP(N)(N)=O.OC1=CC=CC=C1 AUEULUAAXLGHJD-UHFFFAOYSA-N 0.000 description 1
- AFZSMODLJJCVPP-UHFFFAOYSA-N dibenzothiazol-2-yl disulfide Chemical compound C1=CC=C2SC(SSC=3SC4=CC=CC=C4N=3)=NC2=C1 AFZSMODLJJCVPP-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- DOVUCQDMJHKBFO-UHFFFAOYSA-N diethyl 2,6-dimethoxy-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(OC)NC(OC)=C(C(=O)OCC)C1 DOVUCQDMJHKBFO-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000007765 extrusion coating Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000002390 heteroarenes Chemical class 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical class N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- BQPIGGFYSBELGY-UHFFFAOYSA-N mercury(2+) Chemical group [Hg+2] BQPIGGFYSBELGY-UHFFFAOYSA-N 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- DPUIBGVQGAFCEL-UHFFFAOYSA-N n-(anthracen-1-ylmethylideneamino)aniline Chemical compound C=1C=CC2=CC3=CC=CC=C3C=C2C=1C=NNC1=CC=CC=C1 DPUIBGVQGAFCEL-UHFFFAOYSA-N 0.000 description 1
- 125000005487 naphthalate group Chemical group 0.000 description 1
- KYTZHLUVELPASH-UHFFFAOYSA-N naphthalene-1,2-dicarboxylic acid Chemical compound C1=CC=CC2=C(C(O)=O)C(C(=O)O)=CC=C21 KYTZHLUVELPASH-UHFFFAOYSA-N 0.000 description 1
- KHARCSTZAGNHOT-UHFFFAOYSA-N naphthalene-2,3-dicarboxylic acid Chemical compound C1=CC=C2C=C(C(O)=O)C(C(=O)O)=CC2=C1 KHARCSTZAGNHOT-UHFFFAOYSA-N 0.000 description 1
- RXOHFPCZGPKIRD-UHFFFAOYSA-N naphthalene-2,6-dicarboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=CC(C(=O)O)=CC=C21 RXOHFPCZGPKIRD-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 150000002916 oxazoles Chemical class 0.000 description 1
- COWNFYYYZFRNOY-UHFFFAOYSA-N oxazolidinedione Chemical class O=C1COC(=O)N1 COWNFYYYZFRNOY-UHFFFAOYSA-N 0.000 description 1
- 150000002918 oxazolines Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- NFBAXHOPROOJAW-UHFFFAOYSA-N phenindione Chemical compound O=C1C2=CC=CC=C2C(=O)C1C1=CC=CC=C1 NFBAXHOPROOJAW-UHFFFAOYSA-N 0.000 description 1
- 239000013034 phenoxy resin Substances 0.000 description 1
- 229920006287 phenoxy resin Polymers 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000768 polyamine Chemical class 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920005553 polystyrene-acrylate Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- HBCQSNAFLVXVAY-UHFFFAOYSA-N pyrimidine-2-thiol Chemical compound SC1=NC=CC=N1 HBCQSNAFLVXVAY-UHFFFAOYSA-N 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 150000003236 pyrrolines Chemical class 0.000 description 1
- QEIQICVPDMCDHG-UHFFFAOYSA-N pyrrolo[2,3-d]triazole Chemical class N1=NC2=CC=NC2=N1 QEIQICVPDMCDHG-UHFFFAOYSA-N 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 150000003246 quinazolines Chemical class 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- KIWUVOGUEXMXSV-UHFFFAOYSA-N rhodanine Chemical class O=C1CSC(=S)N1 KIWUVOGUEXMXSV-UHFFFAOYSA-N 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 125000001824 selenocyanato group Chemical group *[Se]C#N 0.000 description 1
- CRDYSYOERSZTHZ-UHFFFAOYSA-N selenocyanic acid Chemical class [SeH]C#N CRDYSYOERSZTHZ-UHFFFAOYSA-N 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- AQRYNYUOKMNDDV-UHFFFAOYSA-M silver behenate Chemical group [Ag+].CCCCCCCCCCCCCCCCCCCCCC([O-])=O AQRYNYUOKMNDDV-UHFFFAOYSA-M 0.000 description 1
- 229940100890 silver compound Drugs 0.000 description 1
- 150000003379 silver compounds Chemical class 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- CHLCPTJLUJHDBO-UHFFFAOYSA-M sodium;benzenesulfinate Chemical compound [Na+].[O-]S(=O)C1=CC=CC=C1 CHLCPTJLUJHDBO-UHFFFAOYSA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000001119 stannous chloride Chemical class 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000011115 styrene butadiene Substances 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 150000003452 sulfinic acid derivatives Chemical class 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical class CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- 150000003549 thiazolines Chemical class 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 1
- ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
- 229950000329 thiouracil Drugs 0.000 description 1
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical class NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- UIERETOOQGIECD-ONEGZZNKSA-N tiglic acid Chemical compound C\C=C(/C)C(O)=O UIERETOOQGIECD-ONEGZZNKSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Radiography Using Non-Light Waves (AREA)
- Photographic Developing Apparatuses (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】この発明は、例えばX線マン
モグラフィや四肢骨等の撮影等に用いられるX線画像形
成方法及びX線画像形成システムに関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an X-ray image forming method and an X-ray image forming system used for, for example, X-ray mammography and imaging of limb bones.
【0002】[0002]
【従来の技術】マンモグラフィや四肢骨等のX線撮影等
に用いられるX線画像形成システムとして、X線画像を
フラットパネルディテクタに捕獲し、このフラットパネ
ルディテクタからX線画像を画像信号として取り出し、
例えばサーマルヘッドを用いた熱溶融転写が行われる。2. Description of the Related Art As an X-ray image forming system used for mammography, X-ray imaging of limb bones, etc., an X-ray image is captured by a flat panel detector, and the X-ray image is extracted as an image signal from the flat panel detector.
For example, thermal fusion transfer using a thermal head is performed.
【0003】[0003]
【発明が解決しようとする課題】ところで、X線画像を
フラットパネルディテクタに捕獲し、このフラットパネ
ルディテクタからX線画像を画像信号として取り出すX
線画像の形成システムは、極めて高い鮮鋭性を持つディ
テクターが用いられているが、例えばサーマルヘッドを
用いた熱溶融転写方式では、十分な鮮鋭性が得られなか
った。By the way, an X-ray image is captured by a flat panel detector, and the X-ray image is extracted as an image signal from the flat panel detector.
Although a detector having extremely high sharpness is used in the line image forming system, sufficient sharpness cannot be obtained by, for example, a thermal fusion transfer method using a thermal head.
【0004】また、熱溶融転写方式では、例えば記録ド
ラムを用いて受像フィルム上に記録シートを重ねて転写
するものがあるが、装置が高価で、しかも画像形成が遅
い等の問題があり、フラットパネルディテクタが有する
高鮮鋭性を安価な装置で実現することができなかった。[0004] In the hot-melt transfer method, for example, there is a method in which a recording sheet is superimposed and transferred on an image receiving film using a recording drum. However, there are problems such as an expensive apparatus and slow image formation. The high sharpness possessed by the panel detector cannot be realized with an inexpensive device.
【0005】この発明は、前記実情に鑑みてなされたも
ので、例えばマンモグラフィや四肢骨等に要求される高
い高鮮鋭性と高解像度の高画質のX線画像を迅速に且つ
確実に、しかも安価な装置で得ることができるX線画像
形成方法及びX線画像形成システムを提供することを目
的としている。SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned circumstances, and is capable of quickly, reliably and inexpensively producing high-quality X-ray images of high sharpness and high resolution required for mammography and limb bones, for example. It is an object of the present invention to provide an X-ray image forming method and an X-ray image forming system which can be obtained by a simple apparatus.
【0006】[0006]
【課題を解決するための手段】前記課題を解決し、かつ
目的を達成するために、この発明は、以下のように構成
した。Means for Solving the Problems In order to solve the above problems and achieve the object, the present invention has the following constitution.
【0007】請求項1記載の発明は、『X線画像をフラ
ットパネルディテクタに捕獲し、このフラットパネルデ
ィテクタからX線画像を画像信号として取り出し、感光
性のハロゲン化銀、非感光性の還元性銀源及び銀源のた
めの還元剤を基本的に含有する熱現像感光材料を用い、
前記画像信号を光強度変化に変えて、感光性ハロゲン化
銀粒子に記録し、非感光性の還元性銀源、及び銀源のた
めの還元剤の存在下に加熱してX線画像を得ることを特
徴とするX線画像形成方法。』である。According to the first aspect of the present invention, there is provided a method for capturing an X-ray image by a flat panel detector, extracting the X-ray image from the flat panel detector as an image signal, and using a photosensitive silver halide, a non-photosensitive reducing agent. Using a photothermographic material basically containing a silver source and a reducing agent for the silver source,
The image signal is converted into a change in light intensity, recorded on photosensitive silver halide grains, and heated in the presence of a non-photosensitive reducible silver source and a reducing agent for the silver source to obtain an X-ray image. An X-ray image forming method, comprising: ].
【0008】この請求項1記載の発明によれば、感光性
ハロゲン化銀粒子に記録し、非感光性の還元性銀源及び
銀源のための還元剤の存在下に加熱して熱現像処理する
ことで、例えばマンモグラフィや四肢骨等に要求される
高い高鮮鋭性と高解像度の高画質のX線画像を迅速に且
つ確実に得ることができる。According to the first aspect of the present invention, thermal development processing is performed by recording on photosensitive silver halide grains and heating in the presence of a non-photosensitive reducible silver source and a reducing agent for the silver source. By doing so, it is possible to quickly and reliably obtain a high-quality X-ray image with high sharpness and high resolution required for, for example, mammography and limb bones.
【0009】請求項2記載の発明は、『X線画像をフラ
ットパネルディテクタに捕獲し、このフラットパネルデ
ィテクタからX線画像を画像信号として取り出すX線画
像の形成システムにおいて、前記X線画像信号を光強度
変化に変えて、熱現像感光材料の感光性ハロゲン化銀粒
子に記録し、熱現像感光材料の非感光性の還元性銀源及
び銀源のための還元剤の存在下に加熱してX線画像を得
る熱現像装置を備えることを特徴とするX線画像形成シ
ステム。』である。According to a second aspect of the present invention, there is provided an X-ray image forming system for capturing an X-ray image by a flat panel detector and extracting the X-ray image as an image signal from the flat panel detector. Instead of changing the light intensity, recording on the photosensitive silver halide grains of the photothermographic material, and heating in the presence of a non-photosensitive reducible silver source of the photothermographic material and a reducing agent for the silver source An X-ray image forming system comprising a heat developing device for obtaining an X-ray image. ].
【0010】この請求項2記載の発明によれば、熱現像
装置により感光性ハロゲン化銀粒子に記録し、非感光性
の還元性銀源及び銀源のための還元剤の存在下に加熱
し、熱現像感光材料を熱現像処理することで、例えばマ
ンモグラフィや四肢骨等に要求される高い高鮮鋭性と高
解像度の高画質のX線画像を迅速に且つ確実に、しかも
安価な装置で得ることができる。According to the second aspect of the present invention, the photosensitive silver halide grains are recorded by a heat developing device and heated in the presence of a non-photosensitive reducible silver source and a reducing agent for the silver source. By subjecting the photothermographic material to heat development, high-quality X-ray images with high sharpness and high resolution required for, for example, mammography and limb bones can be obtained quickly, reliably, and at low cost. be able to.
【0011】請求項3記載の発明は、『前記熱現像装置
は、前記熱現像感光材料を搬送する搬送手段と、熱現像
感光材料の感光性ハロゲン化銀粒子に露光して記録する
露光手段と、熱現像感光材料の非感光性の還元性銀源及
び銀源のための還元剤に熱を与える加熱手段と、前記搬
送手段、露光手段及び加熱手段を制御する制御手段とを
備え、前記熱現像感光材料を熱現像処理してX線画像を
得ることを特徴とする請求項2記載のX線画像形成シス
テム。』である。According to a third aspect of the present invention, there is provided an image forming apparatus comprising: a heat transporting device for transporting the photothermographic material; and an exposure device for exposing and recording the photosensitive silver halide particles of the photothermographic material. Heating means for applying heat to a non-photosensitive reducible silver source of the photothermographic material and a reducing agent for the silver source; and control means for controlling the transport means, exposure means and heating means, 3. The X-ray image forming system according to claim 2, wherein an X-ray image is obtained by subjecting the developed photosensitive material to heat development. ].
【0012】この請求項3記載の発明によれば、熱現像
感光材料を搬送し、感光性ハロゲン化銀粒子に露光して
記録し、非感光性の還元性銀源及び銀源のための還元剤
の存在下に加熱し、熱現像感光材料を熱現像処理するこ
とで、例えばマンモグラフィや四肢骨等に要求される高
い高鮮鋭性と高解像度の高画質のX線画像を迅速に且つ
確実に、しかも安価な装置で得ることができる。According to the third aspect of the present invention, the photothermographic material is conveyed and exposed to and recorded on photosensitive silver halide grains, and the non-photosensitive reducible silver source and the reduction for the silver source are reduced. By heating the photothermographic material in the presence of an agent and subjecting the photothermographic material to thermal development processing, high-quality X-ray images with high sharpness and high resolution required for, for example, mammography and limb bones can be quickly and reliably obtained. In addition, it can be obtained with an inexpensive device.
【0013】[0013]
【発明の実施の形態】以下、この発明のX線画像形成方
法及びX線画像形成システムの実施の形態を、図面に基
づいて説明するが、この発明は、この実施の形態に限定
されるものではないことは明らかである。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, an embodiment of an X-ray image forming method and an X-ray image forming system of the present invention will be described with reference to the drawings, but the present invention is not limited to this embodiment. Clearly not.
【0014】図1はX線画像形成システムの概略構成
図、図2はフラットパネルディテクタ(FPD)を示す
概略断面図、図3はフラットパネルディテクタ(FP
D)を示す概略平面図である。FIG. 1 is a schematic configuration diagram of an X-ray image forming system, FIG. 2 is a schematic sectional view showing a flat panel detector (FPD), and FIG. 3 is a flat panel detector (FP).
It is a schematic plan view which shows D).
【0015】X線画像形成システムは、図1に示すよう
に、X線管1から照射されるX線により被写体60の撮
影を行い、X線画像をフラットパネルディテクタ(FP
D)2に捕獲する。このフラットパネルディテクタ(F
PD)からX線画像を画像信号として取り出し、画像処
理部3で画像処理してネットワーク4に送る。ネットワ
ーク4には液晶ディスプレイ5やレーザイメージャー6
等が接続されており、液晶ディスプレイ5にX線画像を
表示したり、レーザイメージャー6でX線画像をプリン
トして出力する。As shown in FIG. 1, the X-ray image forming system captures an image of a subject 60 with X-rays emitted from an X-ray tube 1 and converts the X-ray image into a flat panel detector (FP).
D) Capture in 2. This flat panel detector (F
An X-ray image is extracted from PD) as an image signal, image-processed by an image processing unit 3, and sent to a network 4. The network 4 includes a liquid crystal display 5 and a laser imager 6
Are connected to display an X-ray image on the liquid crystal display 5 or print and output the X-ray image by the laser imager 6.
【0016】FPDの具体例が特開平6−342098
に開示されている。つまり、被写体を透過したX線をa
-Se 層等の光導電層で吸収してX線強度に応じた電荷を
発生させ、その電荷量を画素毎に検知するものである。
他の方式のFPDの例としては、特開平9−90048
に開示されているように、X線を増感紙等の蛍光体層に
吸収させて蛍光を発生させ、その蛍光の強度を画素毎に
設けたフォトダイオード等の光検出器で検知するものが
ある。蛍光の検知手段としては他に、CCDやC−MO
Sセンサを用いる方法もある。A specific example of the FPD is disclosed in JP-A-6-342098.
Is disclosed. That is, the X-ray transmitted through the subject
A charge is generated in accordance with the X-ray intensity by being absorbed by a photoconductive layer such as a -Se layer and the amount of the charge is detected for each pixel.
Japanese Patent Application Laid-Open No. 9-90048 describes an example of another type of FPD.
As disclosed in Japanese Patent Application Laid-Open No. H11-229, an X-ray is absorbed by a phosphor layer such as an intensifying screen to generate fluorescence, and the intensity of the fluorescence is detected by a photodetector such as a photodiode provided for each pixel. is there. Other means for detecting fluorescence include CCD and C-MO.
There is also a method using an S sensor.
【0017】特に上記の特開平6−342098に開示
された方式のFPDでは、X線量を画素毎の電荷量に直
接変換するため、FPDでの鮮鋭性の劣化が少なく、鮮
鋭性の優れた画像が得られるので、本発明のX線画像記
録システム及びX線画像記録方法による効果が大きく好
適である。In particular, in the FPD of the method disclosed in the above-mentioned Japanese Patent Application Laid-Open No. 6-342098, since the X-ray dose is directly converted into the charge amount for each pixel, the sharpness of the FPD is hardly degraded, and the image with excellent sharpness is obtained. Therefore, the effects of the X-ray image recording system and the X-ray image recording method of the present invention are large and suitable.
【0018】フラットパネルディテクタ(FPD)2
は、図2及び図3に示すように構成される。Flat panel detector (FPD) 2
Is configured as shown in FIG. 2 and FIG.
【0019】フラットパネルディテクタ(FPD)2
は、図2に示すように、誘電基板層20に、光導電層2
1、誘電層22、前面導電層23を順に積層して構成さ
れる。誘電基板層20上には、複数の第1の微小導電電
極マイクロプレート24が設けられ、この第1の微小導
電電極マイクロプレート24の寸法によって、フラット
パネルディテクタ(FPD)2が解像できる最小画素の
輪郭が定まる。複数の第1の微小導電電極マイクロプレ
ート24上には、静電容量誘電材25が形成されてい
る。フラットパネルディテクタ(FPD)2から誘電層
22を除いてもX線画像を形成することができ、この発
明を実現できるが、この場合は、電荷蓄積キャパシタ3
6で蓄積された電荷量の保持性やX線画像の鮮鋭度が多
少は低下する可能性がある。Flat panel detector (FPD) 2
Is, as shown in FIG. 2, a photoconductive layer 2
1, a dielectric layer 22, and a front conductive layer 23 are sequentially laminated. A plurality of first micro-conductive electrode microplates 24 are provided on the dielectric substrate layer 20, and the minimum pixel that can be resolved by the flat panel detector (FPD) 2 depending on the size of the first micro-conductive electrode microplate 24. Is determined. On the plurality of first minute conductive electrode microplates 24, a capacitance dielectric material 25 is formed. An X-ray image can be formed even if the dielectric layer 22 is removed from the flat panel detector (FPD) 2, and the present invention can be realized.
There is a possibility that the retention of the amount of charge accumulated in step 6 and the sharpness of the X-ray image may be slightly reduced.
【0020】さらに、誘電基板層20上には、2個の電
極26,27とゲート28を有する複数のトランジスタ
29が積層されている。さらに、誘電基板層20上に
は、複数の第2の微小導電電極マイクロプレート30が
積層されている。Further, a plurality of transistors 29 each having two electrodes 26 and 27 and a gate 28 are stacked on the dielectric substrate layer 20. Further, on the dielectric substrate layer 20, a plurality of second minute conductive electrode microplates 30 are stacked.
【0021】図3に示すように、少なくとも1つのトラ
ンジスタ29は、複数の第2の微小導電電極マイクロプ
レート30をXアドレスライン41とYセンスライン4
2に接続している。電荷蓄積キャパシタ36は、第1の
微小導電電極マイクロプレート24、第2の微小導電電
極マイクロプレート30及び静電容量誘電材25によっ
て形成されている。第2の微小導電電極マイクロプレー
ト30はトランジスタ29の電極27にも接続されてい
る。第1の微小導電電極マイクロプレート24はアース
に接続されている。As shown in FIG. 3, at least one transistor 29 includes a plurality of second minute conductive electrode microplates 30 connected to an X address line 41 and a Y sense line 4.
2 connected. The charge storage capacitor 36 is formed by the first micro-conductive electrode microplate 24, the second micro-conductive electrode microplate 30, and the capacitance dielectric material 25. The second microconductive electrode microplate 30 is also connected to the electrode 27 of the transistor 29. The first micro conductive electrode micro plate 24 is connected to ground.
【0022】トランジスタ29は双方向スイッチの働き
をし、バイアス電圧がXアドレスライン41を介してゲ
ートに印加されたかどうかに応じて、Yセンスライン4
2と電荷蓄積キャパシタ36との間に電流を流す。Transistor 29 acts as a bidirectional switch, depending on whether a bias voltage has been applied to the gate via X address line 41 or not.
A current flows between the capacitor 2 and the charge storage capacitor 36.
【0023】複数の第2の微小導電電極マイクロプレー
ト30間のスペースには、導電電極またはXアドレスラ
イン41、及び導電電極またはYセンスライン42が配
置されている。Xアドレスライン41とYセンスライン
42は、図示のように相互に対してほぼ直交するように
配置されている。Xアドレスライン41とYセンスライ
ン42は、リード線またはコネクタを通して、フラット
パネルディテクタ(FPD)2のサイドまたはエッジに
沿って個別にアクセス可能になっている。A conductive electrode or X address line 41 and a conductive electrode or Y sense line 42 are arranged in a space between the plurality of second micro-conductive electrode microplates 30. The X address line 41 and the Y sense line 42 are arranged so as to be substantially orthogonal to each other as shown in the figure. The X address lines 41 and the Y sense lines 42 are individually accessible along the sides or edges of the flat panel detector (FPD) 2 through leads or connectors.
【0024】Xアドレスライン41の各々は、バイアス
電圧をラインに、したがって、アドレスされるXアドレ
スライン41に接続されたされたトランジスタ29のゲ
ートに印加することによって順次にアドレスされる。こ
れにより、トランジスタ29は導通状態になり、対応す
る電荷蓄積キャパシタ36に蓄積された電荷はYセンス
ライン42に流れると共に、電荷検出器46の入力側に
流れる。電荷検出器46はYセンスライン42上で検出
された電荷に比例する電圧出力を発生する。電荷検出器
46の出力は順次にサンプリングされて、アドレスした
Xアドレスライン41上のマイクロキャパシタの電荷分
布を表す画像信号が得られ、各マイクロキャパシタは1
つのイメージ画素を表す。Xアドレスライン41上の画
素のあるラインから信号が読み出されると、電荷増幅器
はリセットライン49を通してリセットされる。次のX
アドレスライン41がアドレスされ、このプロセスは、
すべての電荷蓄積キャパシタ36がサンプリングされ
て、イメージ全体が読み出されるまで繰り返される。Each of the X address lines 41 is sequentially addressed by applying a bias voltage to the line, and thus to the gate of the transistor 29 connected to the addressed X address line 41. As a result, the transistor 29 is turned on, and the charge stored in the corresponding charge storage capacitor 36 flows to the Y sense line 42 and to the input side of the charge detector 46. Charge detector 46 generates a voltage output proportional to the charge detected on Y sense line 42. The output of the charge detector 46 is sampled sequentially to obtain an image signal representing the charge distribution of the microcapacitors on the addressed X address line 41, where each microcapacitor has 1
Represents one image pixel. When a signal is read from a certain pixel line on the X address line 41, the charge amplifier is reset through the reset line 49. Next X
Address line 41 is addressed, and the process comprises:
All charge storage capacitors 36 are sampled and repeated until the entire image is read.
【0025】レーザイメージャー6では、熱現像装置7
を備えており、図4に示す。図4は熱現像装置の概略構
成図である。In the laser imager 6, the heat developing device 7
And is shown in FIG. FIG. 4 is a schematic configuration diagram of the heat developing device.
【0026】熱現像装置7は、熱現像感光材料Pを搬送
する搬送手段70と、熱現像感光材料Pの感光性ハロゲ
ン化銀粒子に露光して記録する露光手段71と、熱現像
感光材料Pの非感光性の還元性銀源及び銀源のための還
元剤に熱を与える加熱手段72と、搬送手段70、露光
手段71及び加熱手段72を制御する制御手段73とを
備え、熱現像感光材料Pを熱現像処理してX線画像を得
る。The thermal developing device 7 includes a transporting unit 70 for transporting the photothermographic material P, an exposing unit 71 for exposing and recording the photosensitive silver halide particles of the photothermographic material P, A heating means 72 for applying heat to the non-photosensitive reducible silver source and the reducing agent for the silver source; and a control means 73 for controlling the transporting means 70, the exposing means 71 and the heating means 72. An X-ray image is obtained by thermally developing the material P.
【0027】この熱現像装置7では、熱現像感光材料P
を搬送し、感光性ハロゲン化銀粒子に露光して記録し、
非感光性の還元性銀源及び銀源のための還元剤の存在下
に加熱し、熱現像感光材料Pを熱現像処理することで、
例えばマンモグラフィや四肢骨等に要求される高い高鮮
鋭性と高解像度の高画質のX線画像を迅速に且つ確実
に、しかも安価な装置で得ることができる。In the thermal developing device 7, the photothermographic material P
And recording by exposing the photosensitive silver halide grains,
By heating in the presence of a non-photosensitive reducible silver source and a reducing agent for the silver source, and thermally developing the photothermographic material P,
For example, high-quality X-ray images with high sharpness and high resolution required for mammography, limb bones, and the like can be obtained quickly, reliably, and at low cost.
【0028】以下、この発明の熱現像感光材料について
詳細に述べる。この発明の熱現像感光材料は、感光性の
ハロゲン化銀、非感光性の還元性銀源、及び銀源のため
の還元剤を基本的に含有し、熱現像処理法を用いて画像
を形成するものである。熱現像感光材料の詳細は、例え
ば米国特許第3,152,904号、同第3,457,
075号、及びD.モーガン(Morgan)による
「ドライシルバー写真材料(Dry Silver P
hotographic Material)」やD.
モーガン(Morgan)とB.シェリー(Shel
y)による「熱によって処理される銀システム(The
rmally Processed Silver S
ystems)」(イメージング・プロセッシーズ・ア
ンド・マテリアルズ(imaging Process
es and Materials)Neblettc
第8版、スタージ(Sturge)、V.ウォールワ
ース(Walworth)、A.シェップ(Shep
p)編集、第2頁、1969年)などに開示されてい
る。Hereinafter, the photothermographic material of the present invention will be described in detail. The photothermographic material of the present invention basically contains a photosensitive silver halide, a non-photosensitive reducible silver source, and a reducing agent for the silver source, and forms an image using a photothermographic processing method. Is what you do. For details of the photothermographic material, see, for example, U.S. Patent Nos. 3,152,904 and 3,457,
No. 075, and D.A. “Dry Silver Photographic Materials (Dry Silver P) by Morgan
photographic Material) ”and D.C.
Morgan and B.A. Shelley
y) "Heat treated silver system (The
rally Processed Silver S
systems) (Imaging Processes and Materials (imaging Process)
es and Materials) Neblettc
Eighth Edition, Sturge, V.S. Walworth, A .; Shep
p) Edit, page 2, 1969).
【0029】この発明における感光性のハロゲン化銀粒
子について説明する。この発明においては、画像形成後
の白濁を低く抑えるため、及び良好な画質を得るために
平均粒子サイズが小さい方が好ましく、平均粒子サイズ
0.1μm以下がより好ましい。ここでいう粒子サイズ
とは、ハロゲン化銀粒子が立方体或いは、八面体いわゆ
る正常晶である場合には、ハロゲン化銀粒子の稜の長さ
をいう。また、ハロゲン化銀粒子が平板状粒子である場
合には主表面の投影面積と同面積の円像に換算したとき
の直径をいう。ハロゲン化銀は単分散であることが好ま
しい。ここでいう単分散とは、下記式で求められる単分
散度が40以下をいう。更に好ましくは30以下であ
り、特に好ましくは0.1以上20以下となる粒子であ
る。The photosensitive silver halide grains in the present invention will be described. In the present invention, the average particle size is preferably small, and more preferably 0.1 μm or less, in order to suppress white turbidity after image formation and obtain good image quality. The term “grain size” as used herein refers to the length of a ridge of a silver halide grain when the silver halide grain is a cubic or octahedral so-called normal crystal. In the case where the silver halide grains are tabular grains, the diameter refers to a diameter when converted into a circular image having the same area as the projected area of the main surface. The silver halide is preferably monodispersed. Here, the monodispersion means that the degree of monodispersion determined by the following equation is 40 or less. The particle size is more preferably 30 or less, and particularly preferably 0.1 or more and 20 or less.
【0030】単分散度=(粒径の標準偏差)/(粒径の
平均値)×100 ハロゲン化銀粒子の形状としては立方体、八面体、平板
状粒子、球状粒子、棒状粒子、ジャガイモ状粒子などを
挙げることができるが、この発明において特に立方体状
粒子、平板状粒子が好ましい。平板状ハロゲン化銀粒子
を用いる場合の平均アスペクト比は好ましくは2以上1
00以下、より好ましくは3以上50以下がよい。これ
らは米国特許第5,264,337号、第5,314,
798号、第5,320,958号などに記載されてお
り、容易に目的の平板状粒子を得ることができる。更
に、ハロゲン化銀粒子のコーナーが丸まった粒子も好ま
しく用いることができる。ハロゲン化銀粒子外表面とし
ては特に制限はないが、ミラー指数[100]面の占め
る割合が高いことが好ましく、この割合が50%以上、
更には70%以上、特に80%以上であることが好まし
い。ミラー指数[100]面の比率は増感色素の吸着に
おける[111]面と[100]面との吸着依存性を利
用したT.Tani,J.Imaging Sci.2
9,165(1985年)により求めることができる。Monodispersity = (standard deviation of particle size) / (average value of particle size) × 100 The shape of silver halide grains is cubic, octahedral, tabular, spherical, rod-like, potato-like. In particular, cubic grains and tabular grains are preferred in the present invention. When tabular silver halide grains are used, the average aspect ratio is preferably 2 or more and 1 or more.
00 or less, more preferably 3 or more and 50 or less. These are disclosed in U.S. Patent Nos. 5,264,337 and 5,314,
No. 798, 5,320,958, etc., and the desired tabular grains can be easily obtained. Further, grains having rounded corners of silver halide grains can also be preferably used. Although the outer surface of the silver halide grains is not particularly limited, it is preferable that the ratio occupied by the Miller index [100] plane is high, and this ratio is 50% or more.
Further, it is preferably at least 70%, particularly preferably at least 80%. The ratio of the [100] plane of the Miller index is determined by T.M. using the dependence of the adsorption of the sensitizing dye on the [111] plane and the [100] plane. Tani, J .; Imaging Sci. 2
9, 165 (1985).
【0031】ハロゲン組成としては、特に制限はなく、
塩化銀、塩臭化銀、塩沃臭化銀、臭化銀、沃臭化銀、沃
化銀のいずれであってもよい。この発明においては、臭
化銀、あるいは沃臭化銀を好ましく用いることができ
る。特に好ましくは沃臭化銀であり、沃化銀含有率は
0.1モル%以上40モル%以下が好ましく、0.1モ
ル%以上20モル%以下がより好ましい。粒子内におけ
るハロゲン組成の分布は均一であってもよく、ハロゲン
組成がステップ状に変化したものでもよく、あるいは連
続的に変化したものでもよいが、好ましい例として粒子
内部の沃化銀含有率の高い沃臭化銀粒子を使用すること
ができる。また、好ましくはコア/シェル構造を有する
ハロゲン化銀粒子を用いることができる。The halogen composition is not particularly limited.
Any of silver chloride, silver chlorobromide, silver chloroiodobromide, silver bromide, silver iodobromide and silver iodide may be used. In the present invention, silver bromide or silver iodobromide can be preferably used. Particularly preferred is silver iodobromide, and the silver iodide content is preferably from 0.1 mol% to 40 mol%, more preferably from 0.1 mol% to 20 mol%. The distribution of the halogen composition in the grains may be uniform, the halogen composition may be changed stepwise, or may be changed continuously, but as a preferred example, the silver iodide content in the grains is preferred. High silver iodobromide grains can be used. Preferably, silver halide grains having a core / shell structure can be used.
【0032】この発明に用いられる写真乳剤は、P.G
lafkides著Chimieet Physiqu
e Photographique (Paul Mo
ntel社刊、1967年)、G.F.Duffin著
Photographic Emulsion Ch
emistry (The Focal Press
刊、1966年)、V.L.Zelikman et
al著Makingand Coating phot
ographic Emulsion(the Foc
al press刊、1964年)等に記載された方法
を用いて調整することができる。即ち、酸性法、中性
法、アンモニア法等のいずれでもよく、又可溶性銀塩と
可溶性ハロゲン塩を反応させる形成としては、片側混合
法、同時混合法、それらの組合せ等のいずれを用いても
よい。このハロゲン化銀はいかなる方法で画像形成層に
添加されてもよく、このときハロゲン化銀は還元可能な
銀源に近接するように配置する。The photographic emulsion used in the present invention is described in US Pat. G
Chimieet Physique by Lafkides
e Photographique (Paul Mo
ntel, 1967); F. Photographic Emulsion Ch by Duffin
emistry (The Focal Press
Published in 1966); L. Zelikman et
Making and Coating photo by al
optic Emulsion (the Foc
al press, 1964) and the like. That is, any of an acidic method, a neutral method, an ammonia method and the like may be used, and a method of reacting a soluble silver salt with a soluble halide may be any one of a one-sided mixing method, a double-sided mixing method, a combination thereof and the like. Good. The silver halide may be added to the image forming layer by any method, in which case the silver halide is arranged close to the reducible silver source.
【0033】また、ハロゲン化銀は有機酸銀とハロゲン
イオンとの反応による有機酸銀中の銀の一部又は全部を
ハロゲン化銀に変換することによって調製してもよい
し、ハロゲン化銀を予め調製しておき、これを有機銀塩
を調製するための溶液に添加してもよく、又はこれらの
方法の組み合わせも可能であるが、後者が好ましい。一
般にハロゲン化銀は有機銀塩に対して0.75〜30重
量%の量で含有することが好ましい。The silver halide may be prepared by converting a part or all of the silver in the organic acid silver by the reaction between the organic acid silver and the halide ion to silver halide. It may be prepared in advance and added to a solution for preparing an organic silver salt, or a combination of these methods is possible, but the latter is preferred. Generally, the silver halide is preferably contained in an amount of 0.75 to 30% by weight based on the organic silver salt.
【0034】この発明に用いられるハロゲン化銀粒子に
は、Fe、Co、Ru、Rh、Re、Os、Irから選
ばれる金属の錯体を含有することが好ましく、1種類で
も同種あるいは異種の金属錯体を2種以上併用しても良
い。好ましい含有率は銀1モルに対し1×10-9モルか
ら1×10-2モルの範囲が好ましく、1×1-8モルから
1×10-4の範囲がより好ましい。The silver halide grains used in the present invention preferably contain a complex of a metal selected from the group consisting of Fe, Co, Ru, Rh, Re, Os, and Ir. May be used in combination of two or more. The preferred content is in the range of 1 × 10 −9 mol to 1 × 10 −2 mol per mol of silver, more preferably in the range of 1 × 1 −8 mol to 1 × 10 −4 mol.
【0035】この発明においては、遷移金属錯体は、下
記一般式で表される6配位錯体が好ましい。In the present invention, the transition metal complex is preferably a six-coordinate complex represented by the following general formula.
【0036】一般式〔ML6〕m 式中、Mは元素周期表の6〜10族の元素から選ばれる
遷移金属、Lは架橋配位子、mは0、1−、2−,3−
又は4−を表す。Lで表される配位子の具体例として
は、ハロゲン化物(弗化物、塩化物、臭化物、及び沃化
物)、シアン化物、シアナート、チオシアナート、セレ
ノシアナート、テルロシアナート、アジド及びアコの各
配位子、ニトロシル、チオニトロシル等が挙げられ、好
ましくアコ、ニトロシル及びチオニトロシル等である。
アコ配位子が存在する場合には、配位子の一つ又は二つ
を占めることが好ましい。Lは同一でもよく、また異な
っていてもよい。In the formula [ML 6 ] m , M is a transition metal selected from elements of Groups 6 to 10 of the periodic table, L is a bridging ligand, and m is 0, 1-, 2-, 3-.
Or 4-. Specific examples of the ligand represented by L include halides (fluorides, chlorides, bromides, and iodides), cyanides, cyanates, thiocyanates, selenocyanates, tellurocyanates, azides, and aquos. Examples include ligand, nitrosyl, thionitrosyl and the like, and preferred are aquo, nitrosyl and thionitrosyl.
If an aquo ligand is present, it preferably occupies one or two of the ligands. L may be the same or different.
【0037】Mとして、ロジウム(Rh)、ルテニウム
(Ru)、レニウム(Re)及びオスミウム(Os)の
場合の好ましい具体例を示す。As M, preferred specific examples in the case of rhodium (Rh), ruthenium (Ru), rhenium (Re) and osmium (Os) are shown.
【0038】 1:〔RhCl6〕3- 2:〔RuCl6〕3- 3:〔ReCI6〕3- 4:〔RuBr6〕3- 5:〔OsCI6〕3- 6:〔CrCI6〕4- 7:〔Ru(No)CI5〕2- 8:〔RuBr4(H2O)〕2- 9:〔Ru(NO)(H2O)CI4〕- 10:〔RhC15(H2O)〕2- 11:〔Re(NO)CI5〕2− 12:〔Re(NO)CN5〕2- 13:〔Re(NO)CICN4〕2- 14:〔Rh(NO)2CI4〕- 15:〔Rh(NO)(H2O)C14〕- 16:〔Ru(NO)CN5〕2- 17:〔Fe(CN)6〕3- 18:〔Rh(NS)CI5〕2- 19:〔Os(NO)CI5〕2- 20:〔Cr(NO)CI5〕2- 21:〔Re(NO)CI5〕- 22:〔Os(NS)CI4(TeCN)〕2- 23:〔Ru(NS)CI5〕2- 24:〔Re(NS)CI4(SeCN)〕2- 25:〔Os(NS)CI(SCN)4〕2- 26:〔Ir(NO)CI5〕2- コバルト、鉄の化合物については六シアノ金属錯体を好
ましく用いることができる。以下に具体例を記す。[0038] 1: [RhCl 6] 3- 2: [RuCl 6] 3- 3: [reci 6] 3- 4: [RuBr 6] 3- 5: [OSCI 6] 3- 6: [CRCI 6] 4 - 7: [Ru (No) CI 5] 2- 8: [RuBr 4 (H 2 O)] 2- 9: [Ru (NO) (H 2 O ) CI 4 ] - 10: [RhC1 5 (H 2 O)] 2- 11: [Re (NO) CI 5] 2- 12: [Re (NO) CN 5] 2- 13: [Re (NO) cICN 4] 2- 14: [Rh (NO) 2 CI 4] - 15: [Rh (NO) (H 2 O ) C1 4 ] - 16: [Ru (NO) CN 5] 2- 17: [Fe (CN) 6] 3- 18: [Rh (NS) CI 5] 2- 19: [Os (NO) CI 5] 2- 20: [Cr (NO) CI 5] 2- 21: [Re (NO) CI 5] - 22: [Os (NS) CI 4 (TeCN )] 2-23 : [Ru (NS) CI 5] 2- 24: [Re (NS) CI 4 (SeCN ) ] 2- 25: [Os (NS) CI (SCN) 4 ] 2- 26: [Ir (NO) CI 5] For the compounds of 2- cobalt and iron, hexacyano metal complexes can be preferably used. Specific examples are described below.
【0039】 27:[Fe(CN)6]4- 28:[Fe(CN)6]3- 29:[Co(CN)6]3- これらの金属のイオン又は錯体イオンを提供すると化合
物は、ハロゲン化銀粒子形成時に添加し、ハロゲン化銀
粒子中に組み込まれることが好ましく、ハロゲン化銀粒
子の調製、つまり核形成、成長、物理熟成、科学増感の
前後のどの段階で添加してもよいが、特に核形成、成
長、物理熟成の段階で添加するのが好ましく、最も好ま
しくは核形成の段階で添加する。添加に際しては、数回
に渡って分割して添加しもよく、ハロゲン化銀粒子中に
均一に含有させることもできるし、特開昭63−296
03号、特開平2−306236号、同3−16754
5号、同4−76534号、同6−110146号、同
5−273683号等に記載されている様に粒子内に分
布を持たせて含有させることもできる。好ましくは、粒
子内部に分布を持たせることができる。これらの金属化
合物は、水或いは適当な有機溶媒(例えば、アルコール
類、エーテル類、グリコール類、ケトン類、エステル
類、アミド類)に溶解して添加することができるが、例
えば金属化合物の粉末の水溶液もしくは金属化合物とN
aCl、KClとを一緒に溶解した水溶液を、粒子形成
中の水溶性銀塩溶液又は水溶性ハライド溶液中に添加し
ておく方法、或いは銀塩溶液とハライド溶液が同時に混
合されるとき第3の水溶液として添加し、3溶液時混合
の方法でハロゲン化銀粒子を調製する方法、粒子形成中
に必要量の金属化合物の水溶液を反応容器に投入する方
法、或いは、ハロゲン化銀調製時に予め金属のイオン又
は錯体イオンをドープしてある別のハロゲン化銀粒子を
添加して溶解させる方法などがある。27: [Fe (CN) 6 ] 4- 28: [Fe (CN) 6 ] 3 -29: [Co (CN) 6 ] 3-When providing these metal ions or complex ions, the compound: It is preferably added during silver halide grain formation and incorporated into silver halide grains.Preparation of silver halide grains, i.e., nucleation, growth, physical ripening, and addition at any stage before and after chemical sensitization. It is preferably added at the stage of nucleation, growth and physical ripening, and most preferably at the stage of nucleation. Upon addition, the compound may be added in several divided portions, and may be uniformly contained in silver halide grains.
No. 03, JP-A-2-306236 and JP-A-3-16754
No. 5, No. 4-76534, No. 6-110146, No. 5-273683, etc., the particles can be contained in the particles with distribution. Preferably, a distribution can be provided inside the particles. These metal compounds can be added by dissolving them in water or a suitable organic solvent (eg, alcohols, ethers, glycols, ketones, esters, amides). Aqueous solution or metal compound and N
a method in which an aqueous solution in which aCl and KCl are dissolved together is added to a water-soluble silver salt solution or a water-soluble halide solution during grain formation, or a third method in which the silver salt solution and the halide solution are simultaneously mixed. A method of preparing silver halide grains by adding as an aqueous solution and mixing three solutions, a method of charging a required amount of an aqueous solution of a metal compound into a reaction vessel during grain formation, or a method of preparing a metal halide in advance during silver halide preparation. There is a method in which another silver halide grain doped with ions or complex ions is added and dissolved.
【0040】特に、金属化合物の粉末の水溶液もしくは
金属化合物とNaCl、KClとを一緒に溶解した水溶
液を水溶性ハライド溶液に添加する方法が好ましい。粒
子表面に添加するときには、粒子形成直後又は物理熟成
時途中もしくは終了時又は科学熱成時に必要量の金属化
合物の水溶液を反応容器に投入することもできる。In particular, a method of adding an aqueous solution of a powder of a metal compound or an aqueous solution in which a metal compound and NaCl and KCl are dissolved together is added to a water-soluble halide solution. When it is added to the particle surface, a required amount of an aqueous solution of a metal compound can be charged into the reaction vessel immediately after the formation of the particle, during or at the end of physical ripening, or at the time of chemical thermoforming.
【0041】感光性ハロゲン化銀粒子はヌードル法、フ
ロキュレーション法、限外濾過法、電気透析法等の公知
の脱塩法により脱塩することができる。The photosensitive silver halide grains can be desalted by a known desalting method such as a noodle method, flocculation method, ultrafiltration method, and electrodialysis method.
【0042】この発明における感光性ハロゲン化銀粒子
は化学増感されていることが好ましく、増感方法として
はイオウ増感、セレン増感、テルル増感、貴金属増感、
還元増感など公知の増感法を用いることができる。ま
た、これら増感法は2種類以上組み合わせて用いること
もできる。イオウ増感には、チオ硫酸塩、チオ尿素化合
物、無機イオウなどを用いることができる。セレン増
感、テルル増感に好ましく用いられる化合物としては、
特開平9−230527等記載の化合物を挙げることが
できる。貴金属増感法に好ましく用いられる化合物とし
ては、例えば塩化金酸、カリウムクロロオーレート、カ
リウムオーリチオシアネート、硫化金、金セレナイド、
或いは米国特許第2448060号、英国特許第618
061号等に記載されている化合物を挙げることができ
る。還元増感法の具体的な化合物としてはアスコルビン
酸、2酸化チオ尿素、塩化第1スズ、ヒドラジン誘導
体、ボラン化合物、シラン化合物、ポリアミン化合物な
どを用いることができる。また、乳剤のpHを7以上ま
たはpAgを8.3以下に保持して熟成することにより
還元増感することができる。The photosensitive silver halide grains in the present invention are preferably chemically sensitized. Examples of the sensitization method include sulfur sensitization, selenium sensitization, tellurium sensitization, noble metal sensitization,
Known sensitization methods such as reduction sensitization can be used. These sensitization methods can be used in combination of two or more. For sulfur sensitization, thiosulfates, thiourea compounds, inorganic sulfur and the like can be used. Compounds preferably used for selenium sensitization and tellurium sensitization include:
Compounds described in JP-A-9-230527 can be exemplified. Compounds preferably used in the noble metal sensitization method include, for example, chloroauric acid, potassium chloroaurate, potassium aurithiocyanate, gold sulfide, gold selenide,
Alternatively, U.S. Pat. No. 2,448,060, British Patent No. 618,
No. 061 and the like. Specific compounds of the reduction sensitization method include ascorbic acid, thiourea dioxide, stannous chloride, hydrazine derivatives, borane compounds, silane compounds, polyamine compounds, and the like. Further, reduction sensitization can be achieved by ripening the emulsion while maintaining the pH of the emulsion at 7 or more or the pAg at 8.3 or less.
【0043】この発明の熱現像感光材料には、分光増感
色素としてシアニン色素、メロシアニン色素、コンプレ
ックスシアニン色素、コンプレックスメロシアニン色
素、ホロポーラーシアニン色素、スチリル色素、ヘミシ
アニン色素、オキソノール色素、ヘミオキソノール色素
等を用いることができる。例えば、特開昭63−159
841号、同60−140335号、同63−2314
37号、同63−259651号、同63−30424
2号、同63−15245号、米国特許第4,639,
414号、同第4,740,455号、同第4,74
1,966号、同第4,751,175号、同第4,8
35,096号に記載された増感色素が使用できる。The photothermographic material of the present invention contains, as spectral sensitizing dyes, cyanine dyes, merocyanine dyes, complex cyanine dyes, complex merocyanine dyes, holopolar cyanine dyes, styryl dyes, hemicyanine dyes, oxonol dyes, hemioxonol dyes. Etc. can be used. For example, JP-A-63-159
No. 841, No. 60-140335, No. 63-2314
No. 37, No. 63-259,651 and No. 63-30424
No. 2, 63-15245, U.S. Pat.
No. 414, No. 4,740,455, No. 4,74
No. 1,966, No. 4,751,175, No. 4,8
Sensitizing dyes described in JP 35,096 can be used.
【0044】この発明に使用される有用な増感色素は例
えばResearch Disclosure It
em 17643 IV−A項(1978年12月p.
23)、どうItem 1831 X項(1978年8
月p437)に記載もしくは引用された文献に記載され
ている。特に各種レーザーイメージャーやスキャナーの
光源の分光特性に適した分光感度を有する増感色素を有
利に選択することができる。例えば特開平9−3407
8号、同9−54409号、同9−80679号記載の
化合物が好ましく用いられる。Useful sensitizing dyes for use in the present invention include, for example, Research Disclosure It
em 17643 IV-A (p.
23), How Item 1831, Section X (August 1978
Monthly p437) or in the literature cited. In particular, a sensitizing dye having a spectral sensitivity suitable for the spectral characteristics of the light source of various laser imagers and scanners can be advantageously selected. For example, JP-A-9-3407
Compounds described in Nos. 8, 9-54409 and 9-80679 are preferably used.
【0045】有用なシアニン色素は、例えば、チアゾリ
ン核、オキサゾリン核、ピロリン核、ピリシジン核、オ
キサゾール核、チアゾール核、セレナゾール核及びイミ
ダゾール核などの塩基性核を有するシアニン色素であ
る。有名なメロシアニン染料で好ましいものは、上記の
塩基性核に加えて、チオヒダントイン核、ローダニン
核、オキサゾリジンジオン核、チアゾリンジオン核、バ
ルビツール酸核、チアゾリノン核、マロノニトリル核及
びピラゾロン核などの酸性核も含む。Useful cyanine dyes are, for example, cyanine dyes having a basic nucleus such as a thiazoline nucleus, an oxazoline nucleus, a pyrroline nucleus, a pyrididine nucleus, an oxazole nucleus, a thiazole nucleus, a selenazole nucleus and an imidazole nucleus. Preferred among the famous merocyanine dyes are, in addition to the above basic nuclei, acidic nuclei such as thiohydantoin nucleus, rhodanine nucleus, oxazolidinedion nucleus, thiazolinedione nucleus, barbituric acid nucleus, thiazolinone nucleus, malononitrile nucleus and pyrazolone nucleus. Including.
【0046】これらの増感色素は単独に用いても良い
が、それらの組み合わせを用いてもよく、増感色素の組
み合わせは、特に強色増感の目的でしばしば用いられ
る。増感色素とともに、それ自身分光増感作用を持たな
い色素或いは可視光を実質的に吸収しない物質であっ
て、強色増感を示す物質を乳剤中に含んでも良い。有用
な増感色素、強色増感を示す色素の組み合わせ及び強色
増感を示す物質はリサーチ・ディスクロージャー(Re
search Disclosure )176巻17
643(1978年12月発行)第23頁1VのJ項、
或いは前述の特公昭9−25500号、同43−493
3号、特開昭59−19032号、同59−19224
2号などに記載されている。These sensitizing dyes may be used alone or in combination, and a combination of sensitizing dyes is often used particularly for supersensitization. In addition to the sensitizing dye, the emulsion may contain a dye which does not itself have a spectral sensitizing effect or a substance which does not substantially absorb visible light and exhibits supersensitization. Useful sensitizing dyes, combinations of dyes exhibiting supersensitization and substances exhibiting supersensitization are described in Research Disclosure (Re
search Disclosure) Volume 176 17
J. 643 (published December 1978), page 23, 1V,
Alternatively, the aforementioned Japanese Patent Publication Nos. 9-25500 and 43-493.
No. 3, JP-A-59-19032 and JP-A-59-19224.
No. 2, etc.
【0047】この発明において有機銀塩は還元可能な銀
源であり、還元可能な銀イオン源を含有する有機酸及び
ヘテロ有機酸の銀塩、特に長鎖(10〜30、好ましく
は15〜28の炭素原子数)の脂肪族カルボン酸の銀塩
が好ましい。配位子が、4.0〜10.0の銀イオンに
対する錯安定度定数を有する有機又は無機の銀塩錯体も
有用である。例えば次のものがある:有機酸の銀塩(例
えば、没食子酸、シュウ酸、ベヘン酸、ステアリン酸、
パルミチン酸、ラウリン酸、オレイン酸、カプロン酸、
ミリスチン酸、パルミチン酸、マレイン酸、リノール酸
等の塩):銀のカルボキシアルキルチオ尿素塩(例え
ば、1−(3−カルボキシプロピル)チオ尿素、1−
(3−カルボキシプロピル)−3,3−ジメチルチオ尿
素等):アルデヒドとヒドロキシ置換芳香族カルボン酸
とのポリマー反応生成物の銀錯体(例えば、アルデヒド
類(ホルムアルデヒド、アセトアルデヒド、ブチルアル
デヒド等)、ヒドロキシ置換酸類(例えば、サリチル
酸、安息香酸、3.5−ジヒドロキシ安息香酸、5.5
−チオジサリチル酸)、チオ塩類の銀塩又は錯体(例え
ば、3−(2−カルボキシエチル)−4−ヒドロキシメ
チル−4−(チアゾリン−2−チオエン、及び3−カル
ボキシメチル−4−チアゾリン−2−チオエン)、イミ
ダゾール、ピラゾール、ウラゾール、1,2,4−チア
ゾール、及び1H−テトラゾール、3−アミノ−5−ベ
ンジルチオ−1,2,4−トリアゾール、及びベンゾト
リアゾールから選択される窒素酸と銀との錯体又は塩:
サッカリン、5−クロロサリチルアルドキシム等の銀
塩:及びメルカプチド類の銀塩、好適な銀塩の例は、R
esearch Disclosure第17029及
び29963に記載されており、特に好ましい銀源はベ
ヘン酸銀である。In the present invention, the organic silver salt is a reducible silver source, and a silver salt of an organic acid or a heteroorganic acid containing a reducible silver ion source, particularly a long chain (10 to 30, preferably 15 to 28) The silver salt of an aliphatic carboxylic acid having (the number of carbon atoms) is preferred. Organic or inorganic silver salt complexes wherein the ligand has a complex stability constant for silver ions of 4.0 to 10.0 are also useful. Examples include: silver salts of organic acids (eg, gallic acid, oxalic acid, behenic acid, stearic acid,
Palmitic acid, lauric acid, oleic acid, caproic acid,
Salts of myristic acid, palmitic acid, maleic acid, linoleic acid, etc.): carboxyalkylthiourea salt of silver (for example, 1- (3-carboxypropyl) thiourea, 1-
(3-carboxypropyl) -3,3-dimethylthiourea, etc.): silver complex of a polymer reaction product of aldehyde and hydroxy-substituted aromatic carboxylic acid (for example, aldehydes (formaldehyde, acetaldehyde, butyraldehyde, etc.), hydroxy-substitution) Acids (e.g., salicylic acid, benzoic acid, 3.5-dihydroxybenzoic acid, 5.5
-Thiodisalicylic acid), silver salts or complexes of thio salts (eg, 3- (2-carboxyethyl) -4-hydroxymethyl-4- (thiazoline-2-thioene, and 3-carboxymethyl-4-thiazoline-2) -Thioene), imidazole, pyrazole, urazole, 1,2,4-thiazole, and nitrogen acid and silver selected from 1H-tetrazole, 3-amino-5-benzylthio-1,2,4-triazole and benzotriazole Complex or salt with:
Silver salts such as saccharin, 5-chlorosalicylaldoxime: and silver salts of mercaptides, examples of suitable silver salts are
described in Science Disclosure Nos. 17029 and 29963, and a particularly preferred silver source is silver behenate.
【0048】有機銀塩化合物は、水溶性銀化合物と銀と
錯形成する化合物を混合することにより得られるが、正
混合法、逆混合法、同時混合法、特開平9−12764
3号に記載されている様なコントロールドダブルジェッ
ト法等が好ましく用いられる。The organic silver salt compound can be obtained by mixing a water-soluble silver compound and a compound which forms a complex with silver, and includes a forward mixing method, a reverse mixing method, a simultaneous mixing method, and a method described in JP-A-9-12764.
A controlled double jet method as described in No. 3 is preferably used.
【0049】この発明に用いることができる有機銀塩の
形状としては特に制限はないが、短軸と長軸を有する針
状結晶が好ましい。感光性ハロゲン化銀感光材料でよく
知られているように銀塩結晶粒子のサイズとその被覆力
の間の反比例関係は、この発明における熱現像感光材料
においても成立し、すなわち熱現像感光材料の画像形成
部である有機銀塩粒子が大きいと被覆力が小さく、画像
濃度が低くなることを意味することから有機銀塩のサイ
ズを小さくすることが必要である。The shape of the organic silver salt that can be used in the present invention is not particularly limited, but a needle crystal having a short axis and a long axis is preferable. As is well known in photosensitive silver halide photosensitive materials, the inverse relationship between the size of silver salt crystal grains and their covering power also holds in the photothermographic material of the present invention. If the organic silver salt particles as the image forming portion are large, it means that the covering power is small and the image density is low. Therefore, it is necessary to reduce the size of the organic silver salt.
【0050】この発明においては、短軸0.01μm以
上0.20μm以下、長軸0.10μm以上5.0μm
以下が好ましく、短軸0.01μm以上0.15μm以
下、長軸0.10μm以上4.0μm以下が好ましい。
有機銀塩の粒子サイズ分布は単分散であることが好まし
い。単分散とは短軸、長軸それぞれの長さの標準偏差を
短軸、長軸それぞれで割った値の百分率が好ましくは1
00%以下、より好ましくは、80%以下、更に好まし
くは50%以下がよい。有機銀塩の形状の測定方法とし
ては有機銀塩分散物の透過型電子顕微鏡増より求めるこ
とができる。単分散性を測定する別の方法として、有機
銀塩の体積荷重平均直径の標準偏差を求める方法があ
り、体積加重平均直径で割った値の百分率(変動係数)
が好ましくは100%以下、より好ましくは80%以
下、更に好ましくは50%以下である。測定方法として
は例えば液中に分散した有機銀塩にレーザー光を照射
し、その散乱光のゆらぎの時間変化に対する自己相関係
数を求めることにより得られた粒子サイズ(体積荷重平
均直径)から求めることができる。この発明の感光材料
における有機銀塩、特に有機酸銀の塗布量は感光材料m
2あたり0.5〜5.0gが好ましく、さらには1.0
〜3.0gが好ましい。In the present invention, the minor axis is 0.01 μm or more and 0.20 μm or less, and the major axis is 0.10 μm or more and 5.0 μm or less.
The following are preferable, and the short axis is preferably 0.01 μm to 0.15 μm, and the long axis is preferably 0.10 μm to 4.0 μm.
The particle size distribution of the organic silver salt is preferably monodispersed. The monodispersion is preferably a percentage of a value obtained by dividing the standard deviation of the length of each of the short axis and the long axis by each of the short axis and the long axis.
It is preferably at most 00%, more preferably at most 80%, even more preferably at most 50%. The shape of the organic silver salt can be measured by increasing the dispersion of the organic silver salt with a transmission electron microscope. Another method of measuring monodispersity is to determine the standard deviation of the volume-weighted average diameter of the organic silver salt, and the percentage of the value divided by the volume-weighted average diameter (coefficient of variation).
Is preferably 100% or less, more preferably 80% or less, and still more preferably 50% or less. As a measuring method, for example, an organic silver salt dispersed in a liquid is irradiated with a laser beam, and the autocorrelation coefficient with respect to the time change of the fluctuation of the scattered light is obtained from the particle size (volume weight average diameter) obtained. be able to. The coating amount of the organic silver salt, especially the organic acid silver in the light-sensitive material of the present invention,
0.5 to 5.0 g per 2 is preferable, and more preferably 1.0 to 5.0 g.
~ 3.0 g is preferred.
【0051】この発明の熱現像感光材料に好適な還元剤
の例は、米国特許第3,770,448号、同第3,7
73,512号、同第3,593,863号及びRes
earch Disclosure第17029及び2
9963に記載されており、次のものがある。Examples of the reducing agent suitable for the photothermographic material of the present invention are described in US Pat. Nos. 3,770,448 and 3,7,448.
Nos. 73,512, 3,593,863 and Res
Ear Disclosure No. 17029 and 2
9963, and includes the following.
【0052】アミノヒドロキシシクロアルケノン化合物
(例えば、2−ヒドロキシピペリジノ−2−シクロヘキ
セノン):還元剤の前駆体としてアミノリダクトン類
(reduktones)エステル(例えば、ピペリジ
ノヘキソースルダクトンモノアセテート):N−ヒドロ
キシ尿素誘導体(例えば、N−p−メチルフェルニル−
N−ヒドロキシ尿素):アルデヒドまたはケトンのヒド
ラゾン類(例えば、アントラセンアルデヒドフェニルヒ
ドラゾン):ホスファーアミドフェノール類;ホスファ
ーミドアニリン類:ポリヒドロキシベンゼン類(例え
ば、ヒドロキノン、t−ブチルーヒドロキノン、イソプ
ロピルヒドロキノン及び(2,5−ジヒドロキシーフェ
ニル)メチルスルホン):スルフヒドロキサム酸類(例
えば、ベンゼンスルフヒドロキサム酸):スルホンアミ
ドアニリン類(例えば、4−(N−メタンスルホンアミ
ド)アニリン):2−テトラゾリルチオヒドロキノン類
(例えば、2−メチル−5−(1−フェニル−5−テト
ラゾリルチオ)ヒドロキノン):テトラヒドロキノキサ
リン類(例えば、1,2,3,4−テトラヒドロキノキ
サリン):アミドオキシン類:アジン類(例えば、脂肪
族カルボン酸アリールヒドラザイド類とアスコルビン酸
の組み合わせ):ポリヒドロキシベンゼンとヒドロキシ
ルアミンの組み合わせ、リダクトン及び/又はヒドラジ
ン:ヒドロキサン酸類:アジン類とスルホンアミドフェ
ノール類の組み合わせ、α−シアノフェニル酢酸誘導
体:ビス−β−ナフトールと1,3−ジヒドロキシベン
ゼン誘導体の組み合わせ:5−ピラゾロン類:スルホン
アミドフェノール還元剤:2−フェニルインダン−1,
3−ジオン等:クロマン:1,4−ジヒドロピリジン類
(例えば、2,6−ジメトキシ−3,5−ジカルボエト
キシ−1,4−ジヒドロピリジン):ビスフェノール類
(例えば、ビス(2−ヒドロキシ−3−t−ブチル−5
−メチルフェニル)メタン、ビス(6−ヒドロキシ−m
−トリ)メシトール(masitol)、2,2−ビス
(4−ヒドロキシ−3−メチルフェニル)プロパン、
4,5−エチリデン−ビス(2−t−ブチル−6−メチ
ル)フェノール、紫外線感応性アスコルビン酸誘導体及
び3−ピラゾリドン類、中でも特に好ましい還元剤はヒ
ンダードフェノール類である。ヒンダードフェノール類
としては下記一般式(A)で表される化合物が挙げられ
る。Aminohydroxycycloalkenonone compounds (eg, 2-hydroxypiperidino-2-cyclohexenone): aminoreductones esters (eg, piperidinohexoseductactone monoacetate) as precursors of reducing agents ): N-hydroxyurea derivative (for example, Np-methylfernyl-
N-hydroxyureas): hydrazones of aldehydes or ketones (eg, anthracenaldehyde phenylhydrazone): phosphoramide phenols; phosphamide anilines: polyhydroxybenzenes (eg, hydroquinone, t-butyl-hydroquinone, isopropylhydroquinone) And (2,5-dihydroxy-phenyl) methyl sulfone): sulfhydroxamic acids (for example, benzenesulfhydroxamic acid): sulfonamidoanilines (for example, 4- (N-methanesulfonamido) aniline): 2-tetra Zolylthiohydroquinones (eg, 2-methyl-5- (1-phenyl-5-tetrazolylthio) hydroquinone): Tetrahydroquinoxalines (eg, 1,2,3,4-tetrahydroquinoxaline): Amido Synths: azines (eg, a combination of an aliphatic carboxylic acid arylhydrazide and ascorbic acid): a combination of polyhydroxybenzene and hydroxylamine, reductone and / or hydrazine: hydroxanoic acids: a combination of azines and sulfonamidophenols , Α-cyanophenylacetic acid derivative: combination of bis-β-naphthol and 1,3-dihydroxybenzene derivative: 5-pyrazolones: sulfonamidophenol reducing agent: 2-phenylindane-1,
3-dione and the like: chroman: 1,4-dihydropyridines (for example, 2,6-dimethoxy-3,5-dicarbethoxy-1,4-dihydropyridine): bisphenols (for example, bis (2-hydroxy-3- t-butyl-5
-Methylphenyl) methane, bis (6-hydroxy-m
-Tri) mesitol, 2,2-bis (4-hydroxy-3-methylphenyl) propane,
4,5-Ethylidene-bis (2-t-butyl-6-methyl) phenol, UV-sensitive ascorbic acid derivatives and 3-pyrazolidones, among which particularly preferred reducing agents are hindered phenols. Examples of the hindered phenols include compounds represented by the following general formula (A).
【0053】[0053]
【化1】 Embedded image
【0054】式中、Rは水素原子、又は炭素原子数1〜
10のアルキル基(例えば、−C4H9,2,4,4−
トリメチルペンチル)を表し、R’及びR”は炭素原子
数1〜5のアルキル基(例えば、メチル、エチル、t−
ブチル)を表す。In the formula, R represents a hydrogen atom or a group having 1 to 1 carbon atoms.
10 alkyl groups (for example, -C4H9,2,4,4-
R ′ and R ″ represent an alkyl group having 1 to 5 carbon atoms (eg, methyl, ethyl, t-
Butyl).
【0055】一般式(A)で表される化合物の具体例を
以下に示す。ただし、この発明は以下の化合物に限定さ
れるものではない。Specific examples of the compound represented by formula (A) are shown below. However, the present invention is not limited to the following compounds.
【0056】[0056]
【化2】 Embedded image
【0057】[0057]
【化3】 Embedded image
【0058】前記一般式(A)で表される化合物を始め
とする還元剤の使用量は、好ましくは銀1モル当たり1
×10-2〜10モル、特に1×10-2〜1.5モルであ
る。この発明の熱現像感光材料に好適なバインダーは透
明又は半透明で、一般に無色であり、天然ポリマー合成
樹脂やポリマー及コポリマー、その他フィルムを形成す
る媒体、例えばゼラチン、アラビアゴム、ポリ(ビニル
アルコール)、ヒドロキシエチルセルロース、セルロー
スアセテート、セルロースアセテートブチレート、ポリ
(ビニルピロリドン)、カゼイン、デンプン、ポリ(ア
クリル類)、ポリ(メチルメタクリル酸)、ポリ(塩化
ビニル)、ポリ(メタクリル酸)、コポリ(スチレン−
無水マレイン酸)、コポリ(スチレン−アクリロニトリ
ル)、コポリ(スチレン−ブタジエン)、ポリ(ビニル
アセタール)類(例えば、ポリ(ビニルホルマール)及
びポリ(ビニルブチラール))、ポリ(エステル)類、
ポリ(ウレタン)類、フェノキシ樹脂、ポリ(塩化ビニ
リデン)、ポリ(エポキシド)類、ポリ(カーボネー
ト)類、ポリ(ビニルアセテート)、セルロースエステ
ル類、ポリ(アミド)類がある。親水性でも非親水性で
も良い。The amount of the reducing agent such as the compound represented by the formula (A) is preferably 1 to 1 mol per silver.
It is from × 10 -2 to 10 mol, especially from 1 × 10 -2 to 1.5 mol. Binders suitable for the photothermographic material of the present invention are transparent or translucent, generally colorless, and include natural polymer synthetic resins, polymers and copolymers, and other film-forming media such as gelatin, gum arabic, and poly (vinyl alcohol). , Hydroxyethylcellulose, cellulose acetate, cellulose acetate butyrate, poly (vinyl pyrrolidone), casein, starch, poly (acryls), poly (methyl methacrylic acid), poly (vinyl chloride), poly (methacrylic acid), copoly (styrene) −
Maleic anhydride), copoly (styrene-acrylonitrile), copoly (styrene-butadiene), poly (vinyl acetal) s (eg, poly (vinyl formal) and poly (vinyl butyral)), poly (esters),
There are poly (urethanes), phenoxy resins, poly (vinylidene chloride), poly (epoxides), poly (carbonates), poly (vinyl acetate), cellulose esters, and poly (amides). It may be hydrophilic or non-hydrophilic.
【0059】この発明においては、熱現像後の寸法変動
を防ぐ目的として感光性層のバインダー量が1.5〜1
0g/m2であることが好ましい。さらに好ましくは
1.7〜8g/m2である。1.5g/m2未満では、未
露光部の濃度が大幅に上昇し、使用に耐えない場合があ
る。In the present invention, the amount of binder in the photosensitive layer is 1.5 to 1 for the purpose of preventing dimensional fluctuation after thermal development.
It is preferably 0 g / m 2 . More preferably, it is 1.7 to 8 g / m 2 . If it is less than 1.5 g / m 2 , the density of the unexposed portion will increase significantly, and may not be usable.
【0060】この発明においては、感光性層側にマット
剤を含有することが好ましく、熱現像後の画像の傷つき
防止のためには、感光材料の表面にマット剤を配するこ
とが好ましく、そのマット剤を乳剤層側の全バインダー
に対し、重量比で0.5〜10%含有することが好まし
い。In the present invention, a matting agent is preferably contained on the photosensitive layer side, and in order to prevent damage to the image after thermal development, it is preferable to provide a matting agent on the surface of the photosensitive material. The matting agent is preferably contained in a weight ratio of 0.5 to 10% with respect to all binders on the emulsion layer side.
【0061】この発明において用いられるマット剤の材
質は、有機物及び無機物のいずれでも良い。例えば、無
機物としては、スイス特許第330,158号等に記載
のシリカ、仏国特許第1,296,995号等に記載の
ガラス粉、英国特許第1,173,181号等に記載の
アルカリ土類金属又はカドミニウム、亜鉛等の炭酸塩等
をマット剤として用いることができる。有機物として
は、米国特許第2,322,037号等に記載の澱粉、
ベルギー特許第625,451号や英国特許第981,
198号等に記載された澱粉誘導体、特公昭44−36
43号などに記載のポリビニルアルコール、スイス特許
第330,158号等に記載のポリスチレン或いはポリ
メタアクリレート、米国特許第3,079,257号等
に記載のポリアクリロニトリル、米国特許第3,02
2,169号等に記載されたポリカーボネートの様な有
機マット剤を用いることができる。The material of the matting agent used in the present invention may be either an organic substance or an inorganic substance. For example, as inorganic substances, silica described in Swiss Patent No. 330,158, glass powder described in French Patent No. 1,296,995, etc., and alkali described in British Patent No. 1,173,181 etc. An earth metal or a carbonate such as cadmium or zinc can be used as a matting agent. As organic substances, starch described in U.S. Pat. No. 2,322,037, etc.,
Belgian patent 625,451 and British patent 981,
No. 198, etc., JP-B-44-36
No. 43, polystyrene or polymethacrylate described in Swiss Patent No. 330,158, etc., polyacrylonitrile described in US Pat. No. 3,079,257, US Pat. No. 3,02.
An organic matting agent such as polycarbonate described in JP-A-2,169 or the like can be used.
【0062】マット剤の形状は、定形、不定形どちらで
も良いが、好ましくは定形で、球形が好ましく用いられ
る。マット剤の大きさはマット剤の体積を球形に換算し
たときの直径で表される。この発明においてマット剤の
球形とは、この球形換算した直径のことを示すものとす
る。The shape of the matting agent may be either regular or irregular, but is preferably regular and spherical. The size of the matting agent is represented by a diameter when the volume of the matting agent is converted into a sphere. In the present invention, the spherical shape of the matting agent refers to the diameter converted into the spherical shape.
【0063】この発明に用いられるマット剤は、平均粒
径が0.5μm〜10μmであることが好ましく、更に
好ましくは、1.0μm〜8.0μmである。また、粒
子サイズ分布の変動係数としては、50%以下であるこ
とが好ましく、更に好ましくは、40%以下であり、特
に好ましくは30%以下となるマット剤である。The matting agent used in the present invention preferably has an average particle size of 0.5 μm to 10 μm, more preferably 1.0 μm to 8.0 μm. The matting agent has a coefficient of variation of the particle size distribution of preferably 50% or less, more preferably 40% or less, and particularly preferably 30% or less.
【0064】ここで、粒子サイズ分布の変動係数は、下
記の式で表される値である。Here, the variation coefficient of the particle size distribution is a value represented by the following equation.
【0065】 (粒径の標準偏差)/(粒径の平均値)×100 この発明に係るマット剤は任意の構成層中に含むことが
できるが、この発明の目的を達成するためには好ましく
は感光性層以外の構成層であり、更に好ましくは支持体
からみて最も外側の層である。この発明に係るマット剤
の添加方法は、予め塗布液中に分散させて塗布する方法
であっても良いし、塗布液を塗布した後、乾燥が終了す
る以前にマット剤を噴霧する方法を用いても良い。ま
た、複数の種類のマット剤を添加する場合は、両方の方
法を併用しても良い。(Standard deviation of particle size) / (average value of particle size) × 100 The matting agent according to the present invention can be contained in any constituent layer, but is preferably used in order to achieve the object of the present invention. Is a constituent layer other than the photosensitive layer, more preferably the outermost layer as viewed from the support. The method for adding the matting agent according to the present invention may be a method in which the matting agent is dispersed in a coating solution in advance, or a method in which the matting agent is sprayed before the drying is completed after applying the coating solution. May be. When a plurality of types of matting agents are added, both methods may be used in combination.
【0066】この発明の熱現像感光材料は、熱現像処理
にて写真画像を形成するもので、還元可能な銀源(有機
銀塩)、触媒活性量のハロゲン化銀、ヒドラジン誘導
体、還元剤、及び必要に応じて銀の色調を抑制する色調
剤を通常(有機)バインダーマトリックス中に分散した
状態で含有している熱現像感光材料であることが好まし
い。The photothermographic material of the present invention, which forms a photographic image by heat development, comprises a reducible silver source (organic silver salt), a catalytically active amount of silver halide, a hydrazine derivative, a reducing agent, It is preferable that the photothermographic material contains a color tone agent for suppressing the color tone of silver, if necessary, usually in a state dispersed in an (organic) binder matrix.
【0067】この発明の熱現像感光材料は常温で安定で
あるが、露光高温(例えば80℃〜140℃)に加熱す
ることで現像される。加熱することで有機銀塩(酸化剤
として機能する)と還元剤との間の酸化還元反応を通し
て銀を生成する。この酸化還元反応は露光でハロゲン化
銀に発生した潜像の触媒作用によって促進される。露光
領域中の有機銀塩の反応によって生成した銀は黒色画像
を提供し、これは非露光領域と対照をなし、画像の形成
がなされる。この反応過程は、外部から水等の処理液を
供給することなしで進行する。The photothermographic material of the present invention is stable at room temperature, but is developed by heating to a high exposure temperature (for example, 80 ° C. to 140 ° C.). Heating produces silver through an oxidation-reduction reaction between an organic silver salt (functioning as an oxidizing agent) and a reducing agent. This oxidation-reduction reaction is accelerated by the catalytic action of the latent image generated on the silver halide upon exposure. The silver formed by the reaction of the organic silver salt in the exposed areas provides a black image, which contrasts with the unexposed areas, resulting in the formation of an image. This reaction process proceeds without supplying a processing liquid such as water from the outside.
【0068】この発明の熱現像感光材料は支持体上に少
なくとも一層の感光性層を有している。支持体の上に感
光性層のみを形成しても良いが、感光性層の上に少なく
とも1層の非感光性層を形成することが好ましい。感光
性層に通過する光の量又は波長分布を制御するために感
光性層と同じ側又は反対側にフィルター層を形成しても
良いし、感光性層に染料又は顔料を含ませても良い。染
料としては特開平8−201959号の化合物が好まし
い。感光性層は複数層にしてもよく、また階調節のため
感度を高感層/低感層または低感層/高感層にしてもよ
い。各種の添加剤は感光性層、非感光性層、又はそのほ
かの形成層のいずれに添加しても良い。この発明の熱現
像感光材料には例えば、界面活性剤、酸化防止剤、安定
化剤、可塑剤、紫外線吸収剤、被覆助剤などを用いても
良い。The photothermographic material of the present invention has at least one photosensitive layer on a support. Although only a photosensitive layer may be formed on the support, it is preferable to form at least one non-photosensitive layer on the photosensitive layer. A filter layer may be formed on the same side as or opposite to the photosensitive layer to control the amount or wavelength distribution of light passing through the photosensitive layer, or the photosensitive layer may contain a dye or pigment. . As the dye, compounds described in JP-A-8-201959 are preferred. The photosensitive layer may be composed of a plurality of layers, and the sensitivity may be changed to a high-sensitive layer / low-sensitive layer or a low-sensitive layer / high-sensitive layer for controlling the floor. Various additives may be added to any of the photosensitive layer, the non-photosensitive layer, and other layers. The photothermographic material of the invention may contain, for example, a surfactant, an antioxidant, a stabilizer, a plasticizer, an ultraviolet absorber, and a coating aid.
【0069】この発明の熱現像感光材料には、色調剤を
添加することが好ましい。色調剤は、米国特許第308
0254号、同第3847612号及び同第41232
82号に示されるように、写真技術において周知の材料
である。好適な色調剤の例はResearch Dis
closure第17029号に開示されており、次の
ものがある。It is preferable to add a color tone agent to the photothermographic material of the present invention. Toning agents are disclosed in US Pat.
Nos. 0254, 3847612 and 41232
No. 82, it is a material well known in the photographic art. Examples of suitable toning agents are Research Diss
No. 17029, which includes the following:
【0070】イミド類、(例えば、フタルイミド);環
状イミド類、ピラゾリン−5−オン類、及びキナゾリノ
ン(例えば、スクシンイミド、3−フェニル−2−ピラ
ゾリン−5−オン、1−フェニルウラゾール、キナゾリ
ン及び2,4−チアゾリジンジオン):ナフラールイミ
ド類、(例えば、N−ヒドロキシ−1,8−ナフタール
イミド):コバルト錯体(例えば、コバルトのヘキサミ
ントリフルオロアセテート)、メルカプタン類、(例え
ば、3−メルカプト−1,2,4−トリアゾール):N
−(アミノメチル)アリールジカルボキシイミド類、
(例えば、N−(ジメチルアミノメチル)フタルイミ
ド):ブロックされたピラゾール類、イソチウロニウム
(isothiuronium)誘導体及びある種の光
漂白剤の組み合わせ(例えば、N,N’−ヘキサメチレ
ン(1−カルバモイル−3,5−ジメチルピラゾー
ル)、1,8−(3,6−ジオキサオクタン)ビス(イ
ソチウロニウムトリフルオロアセテート)、及び2−
(トリブロモメチルスルホニル)ベンゾチアゾールの組
み合わせ):メロシアニン染料(例えば、3−エチル−
5−((3−エチル−2−ベンゾチアゾリニリデン(ベ
ンゾチアゾリニリデン))−1−メチルエチリデン)−
2−チオ−2,4−オキサゾリジンジオン):フタラジ
ノン、フタラジノン誘導体又はこれらの誘導体の金属塩
(例えば、4−(1−ナフチル)フタラジノン、6−ク
ロロフタラジノン、5,7−ジメチルオキシフタラジノ
ン、及び、2,3−ジヒドロ−1,4−フタラジンジオ
ン):フタラジノンとスルフィン酸誘導体の組み合わせ
(例えば、6−クロロフタラジノン+ベンゼンスルフィ
ン酸ナトリウム又は8−メチルフタラジノン+p−トリ
スルホン酸ナトリウム):フタラジン+フタル酸の組み
合わせ:フタラジン(フタラジンの付加物を含む)とマ
レイン酸無水物、及びフタル酸、2,3−ナフタレンジ
カルボン酸又は0−フェニレン酸誘導体及びその無水物
(例えば、フタル酸、4−メチルフタル酸、4−ニトロ
フタル酸及びテトラクロロフタル酸無水物)から選択さ
れる少なくとも1つの化合物との組み合わせ:キナゾリ
ンジオン類、ベンズオキサジン、ナルトキサジン誘導
体、ベンズオキサジ−2,4−ジオン類(例えば、1,
3−ベンズオキサジン−2,4−ジオン):ピリミジン
類及び不斉−トリアジン類(例えば、2,4−ベンズオ
キサジン−2,4−ジヒドロキシピリミジン)、及びテ
トラアザペンタレン誘導体(例えば、3,6−ジメルカ
プト−1,4−ジフェニル−1H,4H−2,3a,
5,6a−テトラアザペンタレン)。好ましい色調剤と
してはフタラゾン又はフタラジンである。Imides (eg, phthalimide); cyclic imides, pyrazolin-5-ones, and quinazolinones (eg, succinimide, 3-phenyl-2-pyrazolin-5-one, 1-phenylurazole, quinazoline and 2,4-thiazolidinedione): nafuralimides (for example, N-hydroxy-1,8-naphthalimide): cobalt complex (for example, hexamine trifluoroacetate of cobalt), mercaptans, (for example, 3-mercapto-1, 2,4-triazole): N
-(Aminomethyl) aryldicarboximides,
(Eg, N- (dimethylaminomethyl) phthalimide): a combination of blocked pyrazoles, isothiuronium derivatives and certain photobleaches (eg, N, N′-hexamethylene (1-carbamoyl-3, 5-dimethylpyrazole), 1,8- (3,6-dioxaoctane) bis (isothiuronium trifluoroacetate), and 2-
(Combination of (tribromomethylsulfonyl) benzothiazole): Merocyanine dye (for example, 3-ethyl-
5-((3-ethyl-2-benzothiazolinylidene (benzothiazolinylidene))-1-methylethylidene)-
2-thio-2,4-oxazolidinedione): phthalazinone, a phthalazinone derivative or a metal salt of these derivatives (for example, 4- (1-naphthyl) phthalazinone, 6-chlorophthalazinone, 5,7-dimethyloxyphthalazinone) And 2,3-dihydro-1,4-phthalazinedione): a combination of phthalazinone and a sulfinic acid derivative (eg, 6-chlorophthalazinone + sodium benzenesulfinate or 8-methylphthalazinone + p-trisulfonic acid) Sodium): phthalazine + phthalic acid combination: phthalazine (including an adduct of phthalazine) and maleic anhydride, and phthalic acid, 2,3-naphthalenedicarboxylic acid or 0-phenylene acid derivative and its anhydride (for example, phthalic acid) Acid, 4-methylphthalic acid, 4-nitrophthalic acid and tet Combination of at least one compound selected from the chlorophthalic anhydride): quinazoline compounds, benzoxazine, Narutokisajin derivatives, Benzuokisaji 2,4-diones (e.g., 1,
3-benzoxazine-2,4-dione): pyrimidines and asymmetric-triazines (eg, 2,4-benzoxazine-2,4-dihydroxypyrimidine) and tetraazapentalene derivatives (eg, 3,6 -Dimercapto-1,4-diphenyl-1H, 4H-2,3a,
5,6a-tetraazapentalene). Preferred toning agents are phthalazone or phthalazine.
【0071】この発明には現像を抑制或いは促進させ現
像を制御するため、分光増感効率を向上させるため、現
像前後の保存性を向上させるためなどにメルカプト化合
物、ジスルフィド化合物、チオン合物を含有させること
ができる。この発明にメルカプト化合物を使用する場
合、いかなる構造のものでも良いが、ArSM,Ar−
S−S−Arで表されるものが好ましい。式中、Mは水
素原子又はアルカリ金属原子であり、Arは1個以上の
窒素、イオウ、酸素、セレニウム又はテルリウム原子を
有する芳香環または縮合芳香環である。好ましくは、複
素芳香環は、ベンズイミダゾール、ナフトイミダゾー
ル、ベンゾチアゾール、ナフトチアゾール、ベンズオキ
サゾール、ナフトオキサゾール、ベンゾセレナゾール、
ベンゾテルゾール、イミダゾール、オキサゾール、ピラ
ゾール、トリアゾール、チアジアゾール、テトラゾー
ル、トリアジン、ピリミジン、ピリダジン、ピラジン、
ピリジン、プリン、キノリンまたはキナゾリノンであ
る。The present invention contains a mercapto compound, a disulfide compound, and a thione compound in order to suppress or accelerate development to control development, to improve spectral sensitization efficiency, and to improve storage stability before and after development. Can be done. When a mercapto compound is used in the present invention, any structure may be used, but ArSM, Ar-
Those represented by SS-Ar are preferred. In the formula, M is a hydrogen atom or an alkali metal atom, and Ar is an aromatic ring or a condensed aromatic ring having one or more nitrogen, sulfur, oxygen, selenium or tellurium atoms. Preferably, the heteroaromatic ring is benzimidazole, naphthimidazole, benzothiazole, naphthothiazole, benzoxazole, naphthoxazole, benzoselenazole,
Benzoterzole, imidazole, oxazole, pyrazole, triazole, thiadiazole, tetrazole, triazine, pyrimidine, pyridazine, pyrazine,
Pyridine, purine, quinoline or quinazolinone.
【0072】この複素芳香環は、例えば、ハロゲン(例
えばBr及びCl)ヒドロキシ、アミノ、カルボキシ、
アルキル、(例えば、1個以上の炭素原子、好ましくは
1〜4個の炭素原子を有するもの)及びアルコシ(例え
ば、1個以上の炭素原子、好ましくは1〜4個の炭素原
子を有するもの)からなる置換基群から選択されるもの
を有しても良い。メルカプト置換複素芳香族化合物とし
ては、2−メルカプトベンズイミダゾール、2−メルカ
プトベンズオキサゾール、2−メルカプトベンゾチアゾ
ール、2−メルカプト−5−メチルベンズイミダゾー
ル、6−エトキシ−2−メルカプトベンゾチアゾール、
2,2’−ジチオビスベンゾチアゾール、3−メルカプ
ト−1,2,4−トリアゾール、4,5−ジフェニル−
2−イミダゾールチオール、2−メルカプトイミダゾー
ル、1−エチル−2−ムルカプトベンズイミダゾール、
2−メルカプトキノンリン、8−メルカプトプリン、2
−メルカプト−4−(3H)キナゾリノン、7−トリフ
ルオロメチル−4−キノリンチオール、2,3,5,6
−テトラクロロ−4−ピリジンチオール、4−アミノ−
6−ヒドロキシ−2−メルカプトピリジミンモノヒドレ
ート、2−アミノ−5−メルカプト−1,3,4−チア
ジアゾール、3−アミノ−5−メルカプト−1,2,4
−トリアゾール、4−ヒドロキシ−2−メルカプトピリ
ミジン、2−メルカプトピリミジン、4,6−ジアミノ
−2メルカプトピリミジン、2−メルカプト−4−メチ
ルピリミジンヒドロクロリド、3−メルカプト−5−フ
ェニル−1,2,4−トリアゾール、2−メルカプト−
4−フェニルオキサゾール等が挙げられるが、この発明
はこれらに限定されない。これらのメルカプト化合物の
添加量としては、乳剤層中に銀1モルあたり0.001
〜1.0モルの範囲が好ましく、更に好ましくは、銀1
モルあたり0.01〜0.3モルの量である。The heteroaromatic ring includes, for example, halogen (eg, Br and Cl) hydroxy, amino, carboxy,
Alkyl, (eg, having one or more carbon atoms, preferably having 1 to 4 carbon atoms) and alkoxy (eg, having one or more carbon atoms, preferably having 1 to 4 carbon atoms) And a group selected from the group consisting of substituents. Examples of the mercapto-substituted heteroaromatic compound include 2-mercaptobenzimidazole, 2-mercaptobenzoxazole, 2-mercaptobenzothiazole, 2-mercapto-5-methylbenzimidazole, 6-ethoxy-2-mercaptobenzothiazole,
2,2'-dithiobisbenzothiazole, 3-mercapto-1,2,4-triazole, 4,5-diphenyl-
2-imidazole thiol, 2-mercaptoimidazole, 1-ethyl-2-murcaptobenzimidazole,
2-mercaptoquinone phosphorus, 8-mercaptopurine, 2
-Mercapto-4- (3H) quinazolinone, 7-trifluoromethyl-4-quinolinethiol, 2,3,5,6
-Tetrachloro-4-pyridinethiol, 4-amino-
6-hydroxy-2-mercaptopyridimine monohydrate, 2-amino-5-mercapto-1,3,4-thiadiazole, 3-amino-5-mercapto-1,2,4
-Triazole, 4-hydroxy-2-mercaptopyrimidine, 2-mercaptopyrimidine, 4,6-diamino-2mercaptopyrimidine, 2-mercapto-4-methylpyrimidine hydrochloride, 3-mercapto-5-phenyl-1,2,2 4-triazole, 2-mercapto-
Examples thereof include 4-phenyloxazole, but the present invention is not limited thereto. The addition amount of these mercapto compounds is 0.001 per mole of silver in the emulsion layer.
To 1.0 mol, more preferably 1 mol of silver.
The amount is 0.01 to 0.3 mol per mol.
【0073】最も有効なかぶり防止剤として知られてい
るものは水銀イオンである。感光材料中にかぶり防止剤
として水銀化合物を使用することについては、例えば米
国特許第3,589,903号に開示されている。しか
し、水銀化合物は環境的に好ましくない。非水銀かぶり
防止剤としては例えば米国特許第4,546,075号
及び同第4,452,885号及び特開昭59−572
34号に開示されているようなかぶり防止剤が好まし
い。What is known as the most effective antifoggant is mercury ion. The use of a mercury compound as an antifoggant in a light-sensitive material is disclosed in, for example, US Pat. No. 3,589,903. However, mercury compounds are environmentally unfriendly. Examples of the non-mercury antifoggant include U.S. Pat. Nos. 4,546,075 and 4,452,885 and JP-A-59-572.
No. 34 are preferred.
【0074】特に好ましい非水銀かぶり防止剤は、米国
特許第3,874,946号及び同第4,756,99
9号に開示されているような化合物、−C(X1)(X
2)(X3)(ここでX1及びX2はハロゲンでX3は
水素又はハロゲン)で表される1以上の置換基を備えた
ヘテロ環状化合物である。好適なかぶり防止剤の例とし
ては、特開平9−90550号段落番号[0062]〜
[0063]に記載されている化合物などが好ましく用
いられる。Particularly preferred non-mercury antifoggants are disclosed in US Pat. Nos. 3,874,946 and 4,756,993.
No. 9, a compound such as -C (X1) (X
2) A heterocyclic compound having one or more substituents represented by (X3) (where X1 and X2 are halogen and X3 is hydrogen or halogen). Examples of suitable antifoggants include paragraphs [0062] to JP-A-9-90550.
The compounds described in [0063] are preferably used.
【0075】更に、より好適なかぶり防止剤は米国特許
第5,028,523号及び欧州特許631,176号
に開示されている。Further suitable antifoggants are disclosed in US Pat. No. 5,028,523 and EP 631,176.
【0076】この発明における感光層には、可塑剤及び
潤滑剤として多価アルコール(例えば、米国特許第29
60404号に記載された種類のグリセリン及びジオー
ル)米国特許第258765号及び同第3121060
号に記載の脂肪酸またはエステル、英国特許第9550
61号に記載のシリコーン樹脂などを用いることができ
る。In the photosensitive layer according to the present invention, a polyhydric alcohol (for example, US Pat. No. 29
Glycerin and diols of the type described in U.S. Pat. No. 60404) U.S. Pat.
Fatty acids or esters described in British Patent No. 9550
For example, the silicone resin described in No. 61 can be used.
【0077】この発明の感光層、保護層、バック層など
各層には硬膜剤を用いても良い。硬膜剤の例としては、
イソシアネート化合物類、米国特許第4910042号
などに記載されているエポキシ化合物類、特開昭62−
89048号などに記載されているビニルスルホン系化
合物類などが用いられる。A hardener may be used for each layer such as the photosensitive layer, the protective layer and the back layer of the present invention. Examples of hardeners include:
Isocyanate compounds, epoxy compounds described in U.S. Pat. No. 4,910,0042 and the like;
For example, vinylsulfone-based compounds described in JP-A-89048 and the like are used.
【0078】この発明には塗布性、帯電改良などを目的
として界面活性剤を用いても良い。界面活性剤の例とし
ては、アニオン系、カチオン系、ベタイン系、ノニオン
系、フッ素系などいかなるものも適宜用いられる。具体
的には、特開昭62−170950号、米国特許第53
82504号などに記載のフッ素系高分子界面活性剤、
特開昭60−244945号、特開昭63−18813
5号などに記載のフッ素系界面活性剤、米国特許第38
85965号などに記載のポリシロキサン系界面活性
剤、特開平6−301140号などに記載のポリアルキ
レンオキサイドやアニオン系界面活性剤などが挙げられ
る。In the present invention, a surfactant may be used for the purpose of improving coating properties and charging. As an example of the surfactant, any of anionic, cationic, betaine, nonionic, and fluorine-based surfactants can be appropriately used. Specifically, Japanese Patent Application Laid-Open No. Sho 62-170950, U.S. Pat.
No. 82504, etc., a fluoropolymer surfactant,
JP-A-60-244945, JP-A-63-18813
No. 5, fluorinated surfactants described in US Pat.
85965 and the like; polyalkylene oxides and anionic surfactants described in JP-A-6-301140 and the like.
【0079】この発明における熱現像用写真乳剤は、デ
ィップ塗布法、エアナイフ塗布法、フロー塗布法、また
は米国特許第2681294号に記載の種類のホッパー
を用いる押出塗布法を含む種々の塗布方法を用いること
ができる。必要により、米国特許第2761791号及
び英国特許第837095号に記載の方法により2層又
はそれ以上の層を同時に塗布することができる。The photographic emulsion for thermal development in the present invention employs various coating methods including a dip coating method, an air knife coating method, a flow coating method, and an extrusion coating method using a hopper of the type described in US Pat. No. 2,681,294. be able to. If necessary, two or more layers can be applied simultaneously by the methods described in U.S. Pat. No. 2,761,791 and British Patent No. 8,370,955.
【0080】この発明で用いられる支持体は、現像処理
後に所定の光学濃度を得るため、及び現像処理後の画像
の変形を防ぐためにプラスチックフィルム(例えば、ポ
リエチレンテレフタレート、ポリカーボネート、ポリイ
ミド、ナイロン、セルローストリアセテート、ポリエチ
レンナフタレート)であることが好ましい。The support used in the present invention may be a plastic film (for example, polyethylene terephthalate, polycarbonate, polyimide, nylon, cellulose triacetate) in order to obtain a predetermined optical density after development and to prevent image deformation after development. , Polyethylene naphthalate).
【0081】その中でも好ましい支持体としては、ポリ
エチレンテレフタレート(以下PETと略す)、ポリエ
チレンナフタレート(以下PENと略す)、及びシンジ
オタクチック構造を有するスチレン系重合体を含むプラ
スチック(以下SPSと略す)の支持体が挙げられる。
支持体の厚みとしては50〜300μm程度、好ましく
は70〜180μmである。Among them, preferred supports include polyethylene terephthalate (hereinafter abbreviated as PET), polyethylene naphthalate (hereinafter abbreviated as PEN), and plastics containing a styrene-based polymer having a syndiotactic structure (hereinafter abbreviated as SPS). Support.
The thickness of the support is about 50 to 300 μm, preferably 70 to 180 μm.
【0082】また、熱処理したプラスチック支持体を用
いることもできる。採用するプラスチックとしては、前
記のプラスチックが挙げられる。支持体の熱処理とはこ
れらの支持体を製膜後、感光性層が塗布されるまでの間
に、支持体のガラス転移点より、30℃以上高い温度
で、好ましくは35℃以上高い温度で、更に好ましくは
40℃以上高い温度で加熱することがよい。ただし、支
持体の融点を超えた温度で加熱してはこの発明の効果は
得られない。A plastic support which has been heat-treated can also be used. The plastics to be employed include the above-mentioned plastics. The heat treatment of the support means that after forming these supports and before the photosensitive layer is applied, at a temperature higher than the glass transition point of the support by 30 ° C. or higher, preferably by 35 ° C. or higher. It is more preferable to heat at a temperature higher than 40 ° C. However, the effect of the present invention cannot be obtained by heating at a temperature exceeding the melting point of the support.
【0083】次に用いられるプラスチックについて説明
する。Next, the plastic used will be described.
【0084】PETはポリエステルの成分が全てポリエ
チレンテレフタレートからなるものであるが、ポリエチ
レンテレフタレート以外に、酸成分としてテレフタル
酸、ナフタレン−2,6−ジカルボン酸、イソフタル
酸、ブチレンジカルボン酸、5−ナトリウムスルホイソ
フタル酸、アジピン酸等と、グリコール成分としてエチ
レングリコール、プロピレングリコール、ブタンジオー
ル、シクロヘキサンジメタノール等との変性ポリエステ
ル成分が全ポリエステルの10モル以下含まれたポリエ
ステルであっても良い。PET is a polyester in which all of the polyester components are made of polyethylene terephthalate. In addition to polyethylene terephthalate, terephthalic acid, naphthalene-2,6-dicarboxylic acid, isophthalic acid, butylene dicarboxylic acid, and 5-sodium sulfo acid are used as acid components. A polyester containing a modified polyester component of isophthalic acid, adipic acid or the like and a glycol component of ethylene glycol, propylene glycol, butanediol, cyclohexane dimethanol or the like in an amount of 10 mol or less of the entire polyester may be used.
【0085】PENとしては、ポリエチレン2,6ナフ
タレート、及びテレフタル酸と2−6ナフタレンジカル
ボン酸とエチレングリコールからなる共重合ポリエステ
ル、及びこれらのポリエステルの2種類以上の混合物を
主要な構成成分とするポリエステルが好ましい。また、
さらに他の共重合成分が共重合されてもよいし、他のポ
リエステルが混合されていてもよい。Examples of the PEN include polyethylene 2,6 naphthalate, copolymerized polyesters composed of terephthalic acid, 2-6 naphthalenedicarboxylic acid and ethylene glycol, and polyesters containing a mixture of two or more of these polyesters as main components. Is preferred. Also,
Further, another copolymer component may be copolymerized, or another polyester may be mixed.
【0086】SPSは通常のポリスチレン(アタクチッ
クポリスチレン)と異なり立体的に規則性を有したポリ
スチレンである。SPSの規則的な立体規則性構造部分
をラセモ連鎖といい、2連鎖、3連鎖、5連鎖、或いは
それ以上と規則的な部分がより多くあることが好まし
く、この発明において、ラセモ連鎖は、2連鎖で85%
以上、3連鎖で75%以上、5連鎖で50%以上、それ
以上の連鎖で30%以上であることが好ましい。SPS
の重合は特開平3−131843号明細書記載の方法に
準じて行うことができる。SPS is a polystyrene having steric regularity unlike ordinary polystyrene (atactic polystyrene). The regular stereoregular structural part of the SPS is called a racemo chain, and it is preferable that there are more regular parts such as two, three, five, or more. 85% in chain
It is preferable that the ratio is 75% or more for three chains, 50% or more for five chains, and 30% or more for more chains. SPS
Can be carried out according to the method described in JP-A-3-131843.
【0087】この発明に係る支持体の製膜方法及び下引
製造方法は公知の方法を用いることができるが、好まし
くは、特開平9−50094号の段落番号[0030]
〜[0070]に記載された方法を用いることである。As the method for forming a film and the method for producing an undercoat according to the present invention, known methods can be used. Preferably, paragraph No. [0030] of JP-A-9-50094 is used.
To [0070].
【0088】[0088]
【発明の効果】前記したように、請求項1記載の発明で
は、感光性のハロゲン化銀、非感光性の還元性銀源及び
銀源のための還元剤を基本的に含有する熱現像感光材料
を用い、前記画像信号を光強度変化に変えて、感光性ハ
ロゲン化銀粒子に記録し、非感光性の還元性銀源、及び
銀源のための還元剤の存在下に加熱して熱現像処理する
ことで、例えばマンモグラフィや四肢骨等に要求される
高い高鮮鋭性と高解像度の高画質のX線画像を迅速に且
つ確実に得ることができる。As described above, according to the first aspect of the present invention, a photothermographic method basically containing a photosensitive silver halide, a non-photosensitive reducible silver source and a reducing agent for the silver source. Using a material, the image signal is converted into a change in light intensity, recorded on photosensitive silver halide grains, and heated and heated in the presence of a non-photosensitive reducible silver source and a reducing agent for the silver source. By performing the development processing, it is possible to quickly and reliably obtain a high-quality X-ray image with high sharpness and high resolution required for, for example, mammography and limb bones.
【0089】請求項2記載の発明では、熱現像装置によ
り感光性ハロゲン化銀粒子に記録し、非感光性の還元性
銀源及び銀源のための還元剤の存在下に加熱し、熱現像
感光材料を熱現像処理することで、例えばマンモグラフ
ィや四肢骨等に要求される高い高鮮鋭性と高解像度の高
画質のX線画像を迅速に且つ確実に、しかも安価な装置
で得ることができる。According to the second aspect of the present invention, the photosensitive silver halide grains are recorded by a heat developing apparatus, and heated in the presence of a non-photosensitive reducible silver source and a reducing agent for the silver source. By subjecting the photosensitive material to heat development processing, high-quality X-ray images of high sharpness and high resolution required for, for example, mammography and limb bones can be obtained quickly, reliably, and at low cost. .
【0090】請求項3記載の発明は、熱現像感光材料を
搬送し、感光性ハロゲン化銀粒子に露光して記録し、非
感光性の還元性銀源及び銀源のための還元剤の存在下に
加熱し、熱現像感光材料を熱現像処理することで、例え
ばマンモグラフィや四肢骨等に要求される高い高鮮鋭性
と高解像度の高画質のX線画像を迅速に且つ確実に、し
かも安価な装置で得ることができる。According to a third aspect of the present invention, there is provided a photothermographic material which is conveyed, exposed to light-sensitive silver halide grains and recorded, and comprises a non-photosensitive reducible silver source and a reducing agent for the silver source. Heating the photothermographic material down and heat-developing the photothermographic material can quickly and reliably produce high-quality X-ray images with high sharpness and high resolution required for mammography and limb bones, for example, at a low cost. Can be obtained with a simple device.
【図1】X線画像形成システムの概略構成図である。FIG. 1 is a schematic configuration diagram of an X-ray image forming system.
【図2】フラットパネルディテクタ(FPD)を示す概
略断面図である。FIG. 2 is a schematic sectional view showing a flat panel detector (FPD).
【図3】フラットパネルディテクタ(FPD)を示す概
略平面図である。FIG. 3 is a schematic plan view showing a flat panel detector (FPD).
【図4】熱現像装置の概略構成図である。FIG. 4 is a schematic configuration diagram of a heat developing device.
1 X線管 2 フラットパネルディテクタ 3 画像処理部 4 ネットワーク 5 液晶ディスプレイ 6 レーザイメージャー 7 熱現像装置 70 搬送手段 71 露光手段 72 加熱手段 73 制御手段 P 熱現像感光材料 DESCRIPTION OF SYMBOLS 1 X-ray tube 2 Flat panel detector 3 Image processing part 4 Network 5 Liquid crystal display 6 Laser imager 7 Thermal developing device 70 Transport means 71 Exposure means 72 Heating means 73 Control means P Thermal developing photosensitive material
Claims (3)
獲し、このフラットパネルディテクタからX線画像を画
像信号として取り出し、感光性のハロゲン化銀、非感光
性の還元性銀源及び銀源のための還元剤を基本的に含有
する熱現像感光材料を用い、前記画像信号を光強度変化
に変えて、感光性ハロゲン化銀粒子に記録し、非感光性
の還元性銀源、及び銀源のための還元剤の存在下に加熱
してX線画像を得ることを特徴とするX線画像形成方
法。An X-ray image is captured by a flat panel detector, and an X-ray image is taken out from the flat panel detector as an image signal, and is used for a photosensitive silver halide, a non-photosensitive reducing silver source and a silver source. Using a photothermographic material basically containing a reducing agent, converting the image signal into a change in light intensity, recording on a photosensitive silver halide grain, a non-photosensitive reducible silver source, and a silver source X-ray image forming method comprising heating in the presence of a reducing agent for obtaining an X-ray image.
獲し、このフラットパネルディテクタからX線画像を画
像信号として取り出すX線画像の形成システムにおい
て、前記X線画像信号を光強度変化に変えて、熱現像感
光材料の感光性ハロゲン化銀粒子に記録し、熱現像感光
材料の非感光性の還元性銀源及び銀源のための還元剤の
存在下に加熱してX線画像を得る熱現像装置を備えるこ
とを特徴とするX線画像形成システム。2. An X-ray image forming system for capturing an X-ray image by a flat panel detector and extracting the X-ray image as an image signal from the flat panel detector, wherein the X-ray image signal is converted into a change in light intensity. Thermal development in which an X-ray image is recorded by recording on the photosensitive silver halide particles of the photothermographic material and heating in the presence of a non-photosensitive reducible silver source and a reducing agent for the silver source of the photothermographic material An X-ray image forming system comprising an apparatus.
搬送する搬送手段と、熱現像感光材料の感光性ハロゲン
化銀粒子に露光して記録する露光手段と、熱現像感光材
料の非感光性の還元性銀源及び銀源のための還元剤に熱
を与える加熱手段と、前記搬送手段、露光手段及び加熱
手段を制御する制御手段とを備え、前記熱現像感光材料
を熱現像処理してX線画像を得ることを特徴とする請求
項2記載のX線画像形成システム。3. The photothermographic apparatus according to claim 1, wherein the photothermographic material includes a conveying unit for conveying the photothermographic material, an exposing unit for exposing and recording the photosensitive silver halide particles of the photothermographic material, A heating means for applying heat to the photosensitive reducible silver source and a reducing agent for the silver source; and a control means for controlling the transporting means, the exposing means and the heating means, wherein the photothermographic material is subjected to a heat development process. 3. An X-ray image forming system according to claim 2, wherein the X-ray image is obtained by performing the operation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11020932A JPH11316428A (en) | 1998-01-30 | 1999-01-29 | Method and system for forming x-ray image |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10-19794 | 1998-01-30 | ||
JP1979498 | 1998-01-30 | ||
JP11020932A JPH11316428A (en) | 1998-01-30 | 1999-01-29 | Method and system for forming x-ray image |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11316428A true JPH11316428A (en) | 1999-11-16 |
Family
ID=26356651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11020932A Pending JPH11316428A (en) | 1998-01-30 | 1999-01-29 | Method and system for forming x-ray image |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11316428A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140026255A (en) | 2012-08-24 | 2014-03-05 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | Radiation detection panel, radiation imaging device, and diagnostic imaging device |
US9142569B2 (en) | 2010-06-18 | 2015-09-22 | Semiconductor Energy Laboratory Co., Ltd. | Photosensor, semiconductor device including photosensor, and light measurement method using photosensor |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06342098A (en) * | 1992-12-16 | 1994-12-13 | E I Du Pont De Nemours & Co | X-ray-image capturing element using solid state device and method thereof |
JPH08297345A (en) * | 1995-04-26 | 1996-11-12 | Fuji Photo Film Co Ltd | Medical heat developable photosensitive material sensitive to infrared laser beam |
-
1999
- 1999-01-29 JP JP11020932A patent/JPH11316428A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06342098A (en) * | 1992-12-16 | 1994-12-13 | E I Du Pont De Nemours & Co | X-ray-image capturing element using solid state device and method thereof |
JPH08297345A (en) * | 1995-04-26 | 1996-11-12 | Fuji Photo Film Co Ltd | Medical heat developable photosensitive material sensitive to infrared laser beam |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9142569B2 (en) | 2010-06-18 | 2015-09-22 | Semiconductor Energy Laboratory Co., Ltd. | Photosensor, semiconductor device including photosensor, and light measurement method using photosensor |
KR20140026255A (en) | 2012-08-24 | 2014-03-05 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | Radiation detection panel, radiation imaging device, and diagnostic imaging device |
DE102013216406A1 (en) | 2012-08-24 | 2014-03-27 | Semiconductor Energy Laboratory Co.,Ltd. | Radiation detection plate, radiation imaging device and diagnostic imaging device |
US9204849B2 (en) | 2012-08-24 | 2015-12-08 | Semiconductor Energy Laboratory Co., Ltd. | Radiation detection panel, radiation imaging device, and diagnostic imaging device |
DE102013216406B4 (en) * | 2012-08-24 | 2020-02-06 | Semiconductor Energy Laboratory Co.,Ltd. | Radiation detection plate, radiation imaging device and diagnostic imaging device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0933673B1 (en) | X-ray image forming method and x-ray image forming system | |
JP3747651B2 (en) | Photothermographic material | |
JP3724260B2 (en) | Laser exposure method and laser exposure apparatus | |
JPH11316428A (en) | Method and system for forming x-ray image | |
JP3780720B2 (en) | X-ray image recording method | |
JP3786008B2 (en) | Image forming apparatus | |
JP3773101B2 (en) | Image forming apparatus and image forming method | |
JP3584433B2 (en) | Manufacturing method of photosensitive material | |
JP3769945B2 (en) | Photothermographic material | |
JP3968950B2 (en) | Photothermographic material and image forming method | |
JP3992036B2 (en) | Thermal development device | |
JP2000292897A (en) | Device and method for heat development | |
JP2000019681A (en) | Heat-developable photosensitive material | |
JP2003140309A (en) | Optical scanning device, apparatus and method for forming image | |
JPH11352623A (en) | Heat developable photosensitive material and packing method thereof | |
JPH11295846A (en) | Processing method for heat developable photosensitive material and processor therefor | |
JP2000171937A (en) | Heat developable photosensitive material | |
JP2002196449A (en) | Heat developable photosensitive material, image recording method and image forming method | |
JP2002122958A (en) | Heat developable photosensitive material, image recording method and image forming method | |
JP2005077592A (en) | Organic silver salt dispersion and production method thereof, heat developable photosensitive material and production method thereof | |
JP2003075956A (en) | Method for producing thermally developable photosensitive material, thermally developable photosensitive material, and image recording method and image forming method using the same | |
JPH11305386A (en) | Heat developable photosensitive material | |
JPH11305379A (en) | Heat developable photosensitive material | |
JP2003280139A (en) | Heat-developable photosensitive material | |
JP2000352789A (en) | Heat-developable photosensitive material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051115 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060328 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060523 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20060609 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20060721 |